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OUTLINE OF THE THESIS 
 
This PhD Thesis reports the results of my research in the laboratory of Prof. Ezio Ricca 
at the Department of Biology of the Federico II University of Naples, Italy. During 
these three years I focused my studies on the effects of molecules of various origin on 
intestinal epithelial cells and on the role of the microbiota in the gut homeostasis, using 
two different experimental approaches: in vitro and in vivo model systems. The Thesis 
is organized in four chapters addressing specific topics. The first three chapters are 
focused on the effect of bacterial molecules (putative peptides produced by intestinal 
isolates of Lactobacilli spp., CHAPTER 1; Competence and Sporulation Factor –CSF 
produced by intestinal isolates of Bacillus subtilis strains, CHAPTER 2) or plant 
molecules (whole-leaf extracts of Aloe arborescens, CHAPTER 3) on epithelial cells (in 
vitro approach) with particular attention to intestinal epithelial cells, to better 
understand how they affect cellular proliferation and death. CHAPTER 4 analyzes the 
variations of intestinal microbiota composition in rats (in vivo approach) under different 
diet regimens, by using a metagenomic approach.  
In most part of my work, I focused on the crosstalk set between commensal bacteria and 
intestinal epithelial cells, based on microbial quorum-sensing molecules. It is well 
known the intestinal microbiota is a unique ecological niche where microorganisms live 
in a balanced relationship with other species and the host. Our gut microbiota can be 
pictured as a microbial organ placed within a host organ: i) it is composed of different 
cell lineages with a capacity to communicate with one another and the host, ii) it 
consumes, stores, and redistributes energy, iii) it mediates physiologically important 
chemical transformations and iv) it maintains and repairs itself through self-replication. 
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Our relationship with components of this microbiota is often described as commensal 
(one partner benefits and the other is apparently unaffected) as opposed to mutualistic 
(both partners experience increased fitness). However, use of the term commensal 
generally reflects our lack of knowledge, or at least an agnostic (noncommittal) attitude 
about the contributions of most citizens of this microbial society to our own fitness or 
the fitness of other community members (Backhead et al., 2005). It’s well known that 
this relationship is complex and incompletely understood, often involving bidirectional 
signals and interactions that not only influence the behavior of microflora but also host 
responses essential to the maintenance of intestinal homeostasis. In this contest, many 
beneficial bacteria, including members of the Lactobacillus or Bacillus genera, have 
been promoted as probiotics for the treatment or prevention of a number of diseases 
(Hong et al., 2005). The mechanism(s) by which they exert their protective effects in 
the gastrointestinal tract is not well understood but is likely to involve pathogen control 
or exclusion as well as protection of host tissues against inflammatory responses. 
However, the biochemical basis of the biological response of eukaryotes to bacterial 
quorum-sensing signal molecules is still at an early stage, and virtually nothing is 
known about the impact of Gram-positive peptide signals on host cells. Furthermore, it 
has to be underlined that all bacilli and lactobacilli used in my studies are intestinal 
isolates from healthy human adult volunteers, previously characterized (Fakhry et al., 
2008; Fakhry et al., 2009). Here a brief summary of the content of each chapter is 
reported. 
 
In CHAPTER 1, I report the effects of secreted molecules of an intestinal strain of 
Lactobacillus gasseri (SF1183) on HCT116 cells, a model of intestinal epithelial cells. 
With my work I have shown that the bacterial strain secretes, during its stationary phase 
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of growth, a small molecule, most likely a peptide, able to reduce the TNF-alpha 
induced-apoptosis of HCT116 cells. These results have been published in 2013: Di 
Luccia B, Manzo N, Baccigalupi L, Calabrò V, Crescenzi E, Ricca E, Pollice A. (2013). 
Lactobacillus gasseri SF1183 affects intestinal epithelial cell survival and growth. 
PLoS One. 2013 Jul 23;8(7):e69102.  
 
In CHAPTER 2, I studied the effects of the Competence and Sporulation Factor (CSF) 
secreted by various intestinal strains of Bacillus subtilis on HT29, used as a model of 
intestinal epithelial cells. CSF is a cationic pentapeptide corresponding to the C-
terminal 5 amino acids of the 40 amino acid polypeptide encoded by the phrC gene 
(Kunst et al., 1997) and acts in quorum sensing factor (Lazazzera et al., 1997) altering 
Bacillus population behavior in pure culture (Solomon et al.,1996). It has been shown 
that CSF produced by a laboratory collection strain of B. subtilis, induces the heat-
shock protein 27 (Hsp27) in human intestinal epithelial cells (Fujita et al., 2007). Hsps 
confer protection against a wide variety of stresses protecting intestinal epithelial cells 
from oxidative injury and hence contribute to the maintenance of intestinal 
homoeostasis (Tao et al., 2006). During my studies, I developed a genetic system to 
evaluate the presence of CSF in bacterial conditioned growth media and used it to 
screen a collection of intestinal isolates of B. subtilis. When compared to a laboratory 
strain of B. subtilis (PY79) most isolates were shown to produce high amounts of CSF 
and only few of them were unable to produce the quorum-sensing peptide. Some of the 
intestinal isolates were able to grow anaerobically and also in those condition CSF 
production was observed. As expected, all CSF-containing media were able to induce 
Hsp27 to levels similar to those observed with the laboratory collection strain and after 
heat shock. Surprisingly, one of the strain that does not produce CSF is still able to 
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induce an heat-shock response, suggesting the also other bacterial molecules can be 
sensed by epithelial cells. Then, a proteomic approach was used to investigate potential 
other cell targets of the bacterial molecule. The total proteic extracts of HT29 cells 
treated and not-treated with CSF were analysed by 2D-PAGE-MS/MS to identify 
proteins up- or down-regulated in the treated sample compared with the not-treated. A 
preliminary analysis of the proteins affected by CSF is reported. A manuscript reporting 
these results is in preparation. 
 
In the CHAPTER 3, it has been proposed a biochemical and cellular approach to explore 
the beneficial activity of Aloe arborescens leaf-extracts. Aloe arborescens is known to 
be rich in beneficial phytotherapeutic, anticancer, and radio-protective properties. It is 
commonly used as a pharmaceutical ingredient for its effect in burn treatment and 
ability to increase skin wound healing properties. However, very few studies have 
addressed its biological effects at molecular level. In this contest, my experiments 
showed that Aloe arborscens extracts have antiproliferative properties on epithelial 
cancer cells and prodifferentiative effects on immortalized cheratinocytes promoting the 
production of antimicrobial molecules. These results have been included in the 
publication: Di Luccia B, Manzo N, Vivo M, Galano E, Amoresano A, Crescenzi E, 
Pollice A, Tudisco R, Infascelli F, Calabrò V. (2013). A biochemical and cellular 
approach to explore the antiproliferative and prodifferentiative activity of Aloe 
Arborescens leaf extract. Phytother Res. doi: 10.1002/ptr.4939. 
 
Moreover, I studied the changes of microbiota composition in rats fed with different 
diets by using a metagenomic approach (CHAPTER 4), to investigate how these 
variations could affect the physiology of the whole organism. The Western diet, rich in 
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fat and carbohydrates, has been clearly associated to the development of obesity and 
diabetes in several industrialized countries. Fructose, an abundant component of the 
western diet, has been proposed as a major inducer of the metabolic syndrome, a 
combination of health disorders significantly increasing the risk of developing obesity 
and diabetes. In addition to being associated to the human health, the diet is known to 
strongly affect the composition of the gut microbiota. However, it is still not clear 
whether the alteration of the microbial composition of the gut is a consequence or rather 
one of the causes of the health disorders due to the diet. We used a rat model of obesity 
to assess whether the gut microbiota was linked to the development of the fructose-
induced metabolic syndrome and showed that an antibiotic treatment as well as a fecal 
transplant was able to abolish early signs of fructose-induced metabolic syndrome. A 
metagenomic approach was used to evaluate the bacterial composition of the gut of rats 
under the various diet regimens. These data point to the reduced bacterial diversity of 
the gut as one of causative factors of the metabolic syndrome. A manuscript 
summarizing these results has been just submitted for publication. 
 
Finally, in the APPENDIX of the thesis I report an unrelated study about the 
characterization of a pigmented spore-forming bacterium (Bacillus pumilus SF214) able 
to produce a hydrosoluble orange carotenoid. Although I don’t discuss in details this 
argument here, I published the results of this work in 2013: Manzo N, Di Luccia B, 
Isticato R, D'Apuzzo E, De Felice M, Ricca E. (2013). Pigmentation and sporulation 
are alternative cell fates in Bacillus pumilus SF214. PLoS One. 2013 Apr 
25;8(4):e62093. Briefly, I observed that in B. pumilus SF214 the pigmentation is strictly 
regulated and high pigment production was observed during the late stationary growth 
phase in a minimal medium and at growth temperatures lower than the optimum. Only a 
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subpopulation of stationary phase cells produced the pigment, indicating that the 
stationary culture contains a heterogeneous cell population and that pigment synthesis is 
a bimodal phenomenon. The fraction of cells producing the pigment varied in the 
different growth conditions and occured only in cells not devoted to sporulation. Only 
some of the pigmented cells were also able to produce a matrix. Pigment and matrix 
production in SF214 appear then as two developmental fates both alternative to 
sporulation. Since the pigment has an essential role in the cell resistance to oxidative 
stress conditions, we propose that within the heterogeneous population different 
survival strategies can be followed by the different cells. 
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1.1 Abstract 
It is now commonly accepted that the intestinal microbiota plays a crucial role in the gut 
physiology and homeostasis, and that both qualitative and quantitative alterations in the 
compositions of the gut flora exert profound effects on the host’s intestinal cells. In 
spite of this, the details of the interaction between commensal bacteria and intestinal 
cells are still largely unknown and only in few cases the molecular mechanisms have 
been elucidated. Here we analyze the effects of molecules produced and secreted by 
Lactobacillus gasseri SF1183 on human intestinal HCT116 cells. L. gasseri is a well 
known species of lactic acid bacteria, commonly associated to the human intestine and 
SF1183 is a human strain previously isolated from an ileal biopsy of an healthy 
volunteer. SF1183 produces and secretes, in a growth phase-dependent way, 
molecule(s) able to drastically interfere with HCT116 cell proliferation. L. gasseri 
molecule(s) stimulate a G1-phase arrest of the cell cycle by up-regulation of p21WAF1 
rendering cells protected from intrinsic and extrinsic apoptosis. 
 
1.2 Introduction 
Several recent studies have shown that commensal bacteria, forming the human gut 
microbiota, establish complex symbiotic interactions with cells of the gastrointestinal 
tract (GIT) and that these interactions significantly contribute to human health [1,2,3,4]. 
Metagenomic experiments have indicated that the vast majority of the intestinal bacteria 
belong to two phyla, the Gram-negative Bacteroidetes and the Gram-positive 
Firmicutes, including the large class of Clostridia and the lactic acid bacteria [5,6]. 
However, the composition of the gut microbiota is known to change transiently as a 
consequence of a variety of factors such as age, diet, enteral infections, pharmacological 
treatments and immunosuppression [7,8,9]. Changes in the microbiota composition 
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have also been associated to several diseases, such as chronic inflammation of the 
Gastro-Intestinal tract (GIT), diabetes and obesity [7,10,11,12,13,14], and the oral 
administration of members of the microbiota has been considered as a potential clinical 
tool to relieve intestinal dysfunctions [15,16,17,18,19,20]. Interest in the beneficial 
functions of the human microbiota has resulted in the selection of specific strains with 
putative health-promoting capacities that are recognized as probiotics and are generally 
selected from isolates of the Lactobacillus or Bifidobacterium species. Probiotic 
bacteria have been shown capable to modulate systemic inflammation, cell proliferation 
and apoptosis, and such properties proposed as useful for future immunomodulatory and 
cancer prevention strategies [13,14,21,22]. In vitro studies have reported the anti-
proliferative and pro-apoptotic effects of Lactobacillus and Bifidobacterium spp. in 
various cancer cell lines [23,24,25,26], while in vivo studies have shown the inhibitory 
activity of probiotics on liver, bladder and colon tumours in animal models 
[27,28,29,30]. 
The molecular mechanisms of interaction between intestinal cells and bacteria have 
been studied in detail only in few cases and often quorum-sensing autoinducers, 
communication molecules released by bacteria at high densities, have been shown to 
modulate host responses either directly or through regulation of bacterial genes 
involved in gut colonization and host signalling [31,32]. An example in this context is 
the quorum-sensing pentapeptide CSF (Competence and Sporulation Factor) of Bacillus 
subtilis that is taken up by Caco-2 cells via the membrane transporter OCTN2 (organic 
cation transporter 2) and that contributes to eukaryotic cell homeostasis activating 
survival pathways (p38 MAP kinase and protein kinase B/ Akt) [33]. In other cases the 
secreted bacterial effectors have not been identified: still unidentified molecules 
secreted by Lactobacillus rhamnosus GG were shown to prevent cytokine-induced 
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apoptosis on two different intestinal cell model systems (YAMC-young adult mouse 
colon; HT29-colon carcinoma) [34]; molecules secreted by L. reuteri were shown to 
potentiate tumour necrosis factor (TNF-α)-induced apoptosis in myeloid leukemia 
derived cells. In the latter example L. reuteri molecules were found to: i) suppress NF-
kB activation by inhibiting IkBa degradation; ii) downregulate nuclear factor-kB (NF-
kB)-dependent gene products affecting cell proliferation and survival; iii) promote 
apoptosis by enhancing mitogen-activated protein kinase (MAPK) activities including 
c-Jun N-terminal kinase and p38 MAPK [35]. 
Lactobacillus gasseri is a well characterized species of low GC gram-positive bacteria, 
known to represent one of the major homofermentative Lactobacillus of the human 
intestine [36]. We have isolated the SF1183 strain of L. gasseri from an ileal biopsy of a 
human healthy volunteer and, in particular, from the fraction of bacteria tightly 
associated to the epithelial cells. SF1183 was shown to have antimicrobial activity 
against a panel of enteropathogens and to form a matrix (biofilm) in standard laboratory 
as well as in simulated intestinal conditions [36].!
This study investigates the effects of molecules produced and secreted by L. gasseri 
SF1183 on colorectal HCT116 cells, both at the molecular and cellular level. Since 
HCT116 cells are responsive to TNFα-induced apoptosis [37,38], we tested their 
response to the presence of L. gasseri SF1183 supernatant. Moreover, we extended our 
analysis to the effects of another inducer of apoptosis to evaluate the specificity of the 
observed effect.  
 
1.3 Results and Discussion 
1.3.1 The conditioned medium (CM) of L. gasseri SF1183 protects HCT116 cells 
from TNFα  induced apoptosis. Among the most common features of chronic 
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intestinal inflammations, such as Crohn and irritable bowel diseases (IBDs), is the 
increase in the production of inflammatory cytokines, epithelial cell apoptosis and 
immune cell infiltration, leading to disruption of the intestinal epithelial integrity. 
TNFα is among the cytokines more largely produced under these conditions. It is 
known to regulate both anti- and pro-apoptotic signaling pathways and determine the 
cell fate by controlling the balance between the two pathways [39]. To study the effects 
of molecules secreted by L. gasseri on TNFα-induced apoptosis we used the TNFα 
sensitive HCT116 human colon cancer cells as a model of intestinal epithelial cells [37]. 
As a marker of apoptosis we followed the proteolytic cleavage of PARP-1, a regulator 
of the DNA base excision repair pathway essential for the maintenance of genomic 
integrity and for survival in response to genotoxic insults [40]. PARP-1 is known to be 
specifically proteolysed by the Caspase 3 to a 24 kDa DNA-binding domain (DBD) and 
a 89 kDa catalytic fragment during the execution of the apoptotic program [41]. To set 
up the experimental conditions, HCT116 cells were incubated with 1 nM TNFα for 
various times and cell extracts analyzed by western blotting with anti-PARP-1 antibody. 
As shown in Figure 1A, the amount of proteolyzed PARP-1 increased with the time of 
exposure to TNFα.  Therefore we decided to use 8 hours of treatment with 1 nM TNFα 
to detect either induction or inhibition of PARP cleavage, for all therein experiments 
involving a TNF-α activation. 
A filter-sterilized conditioned medium (CM) of a L. gasseri SF1183 culture was added 
(20% v/v) to HCT116 cells and incubated for 16 hours. Then, TNFα was added and, 
after additional 8 hours of incubation, cells were harvested and whole extracts analyzed 
by western blotting with anti-PARP-1 antibody. As shown in Figure 1B the bacterial 
CM alone did not have any effect on PARP-1 cleavage while was able to significantly 
reduce the TNFα-induced proteolytic activation of PARP-1. 
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L. gasseri is a homofermentative bacterium that, therefore, grows producing lactic acid 
as the only metabolic end-point of carbohydrate metabolism.  
 
Fig 1. HCT116 cell response to L. gasseri CM with or without TNFα  treatment. 
Western blot with anti-PARP-1 antibody of whole cell extracts from HCT116 cells 
incubated in (A) complete cell culture medium supplemented or not with TNFα (1 nM) 
for 2, 8 or 24 hours; (B) complete cell culture medium supplemented or not with CM 
(20%v/v) for 16 hours before treatment with 1nM TNFα for 8 hours; (C) complete cell 
culture medium supplemented or not with TNFα (1 nM) for 8 hours and MDM (20%v/v) 
or MDM + lactic acid pH4 (20%v/v). After the treatments cells were collected, lysed 
and protein concentration determined. Equal amount of cell lysates were fractionated 
on SDS-PAGE and analyzed by western blotting with antibodies against PARP-1. Actin 
was used as a loading control. 
 
As a consequence, its growth medium is acidified during growth to reach a final pH 
value of 4.0. To verify that the reduction in the extent of PARP-1 cleavage was due to 
secreted molecules and not to the acidification of the growth medium, the same 
experiment of Figure 1B was performed adding to HCT116 cells the same amount (20% 
v/v) of the fresh bacterial growth medium (MDM) either at its normal pH (pH 7.0) or 
acidified to pH 4.0 with lactic acid. As shown in Fig. 1C, both media did not have any 
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effect on TNFα-induced cleavage of PARP-1 suggesting that the CM of L. gasseri 
SF1183 contains molecules with anti-apoptotic activity. 
 
1.3.2 The CM of L. gasseri SF1183 contains bioactive soluble molecule(s) secreted 
during the stationary phase of growth. As a first step toward the characterization of 
molecule(s) involved in the observed effect, we decided to size-separate the CM of L. 
gasseri by using a 3 kDa molecular mass cut-off filter. As Figure 2A clearly shows we 
observed bioactivity largely in the filtrate, indicating a small (less than 3 kDa) 
molecular mass for the effector(s) molecule(s). Further, different enzymatic treatments 
of the CM indicated that bioactivity is proteinase-K sensitive, suggesting a 
proteinaceous nature (Figure 2B). Often bacteria secrete bioactive molecules during 
their stationary phase of growth. We thus tested the CM of L. gasseri cultures at 
different stages of growth and observed bioactivity produced only in early and late 
stationary phase of growth (24 and 48 hours of growth, respectively) (Figure 2). All 
experiments therein reported have been performed by using the size-fractionated (< 3 
kDa) CM of a late stationary culture of L. gasseri SF1183. 
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Fig. 2 L. gasseri secretes bioactive soluble molecule(s) of proteinaceous nature 
during the stationary phase of growth. HCT116 cells were incubated in complete cell 
culture medium supplemented or not with TNFα (1 nM) for 8 hours and with A) CM 
fractionated with a cut-off of 3 kDa, or B) CM treated with different enzymes [Trypsin, 
Proteinase K, DNAse I, RNAse A], or C) CM of cultures at the indicated phases of 
growth. After the treatments, cells were collected, lysed and total cell extracts were 
analyzed by western blotting with antibodies against PARP-1. Actin was used as a 
loading control. PARP-1 band intensity was evaluated by ImageQuant analysis on at 
least two different expositions to assure the linearity of each acquisition. Values 
expressed as ratio with the corresponding actin values and normalised to the reference 
point (PARP-1 cleavage in medium). Percentage of increase (+) or decrease (—) with 
respect to the intensity of the reference point are indicated.  
 
1.3.3 The CM of L. gasseri SF1183 affects cell proliferation of HCT116 cells. To 
characterize the cellular response to L. gasseri secreted molecules, we analyzed 
HCT116 cell number and viability after growth in presence of CM. Briefly, cells were 
incubated for 24 hours with CM of L. gasseri (20% vol/vol) and then analyzed both for 
the number of cells by counting in a Burker chamber and for cell viability by MTS 
assay. As Figure 3A shows, the CM caused a 30% reduction in the number of cells. The 
MTS assay (Figure 3B) showed a reduction in cell viability of the same order of 
magnitude. 
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Fig. 3. The CM of L. gasseri SF1183 affects HCT116 cell number but not cell 
viability. Proliferating HCT116 cells were incubated in complete cell culture medium 
supplemented or not with CM (20%v/v). After 24 hours (A) controls (NT) and CM-
treated (CM) cells were collected and counted in a Burker chamber; or (B) incubated 
with 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium as a substrate and the absorbance of converted formazan measured at 
490nm. 
 
To get more insights into the cellular response, we looked at the cell-cycle distribution 
profile and at the expression of cell cycle-related molecular markers in HCT116 cells 
exposed to TNFα and/or to the CM of L. gasseri. 
The cell cycle distribution was analyzed by flow cytometry and showed that treatment 
with TNFα causes a drastic increase in the subG1 cell population (from 4 to 28%) while 
the pre-treatment of cells with the CM of L. gasseri strongly reduced the TNFα induced 
effect (Figure 4A), thus supporting our previous data indicating a reduction in the extent 
of PARP-1 cleavage (see Figure 1B, 2B, 2C). Importantly, we found that the CM alone 
caused a significant increase (up to 18%) in the G1 population of cells with a 
compensatory decrease in S/G2 cells, indicating that cells were unable to resume the 
cell cycle at normal phase transit rate (Figure 4A), consistently with previous MTS and 
proliferation data. This suggests that, indeed, molecules secreted from L. gasseri can 
drastically interfere with proliferation of HCT116 cells, rendering them less prone to 
TNFα induced apoptosis.  
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Expression of the cell cycle markers p21WAF1 and pERKs was also investigated to 
explore the effects of the CM of L. gasseri at the molecular level. p21WAF1 (also 
known as cyclin-dependent kinase inhibitor 1) is a regulator of cell cycle progression at 
the S phase that acts as an inhibitor of cyclin-dependent kinase, and occupies a central 
position in the regulation of the cell cycle in many tissues [42,43].  
 
 
Fig. 4 The CM of L. gasseri SF1183 affects cell proliferation of HCT116 cells. 
Proliferating HCT116 cells were incubated in complete cell culture medium 
supplemented or not with CM (20%v/v) and/or TNFα (1nM). After the treatments, cells 
were collected and treated for flow-cytometric analysis (A) or western blot (B) with the 
indicated antibodies.  
 
Levels of p21WAF1 protein are regulated during the cell cycle at the levels of 
transcription and protein degradation, although many questions remain on the 
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mechanism of p21 proteolysis [44,45]. ERK1,2 (Extracellular signal-regulated kinases) 
are members of the mitogen-activated protein kinase (MAPK) super family that can 
mediate cell proliferation and apoptosis. Activated (phosphorylated) ERKs, are usually 
associated with active cell proliferation [46], while p21 increase correlates with a G1 
cell cycle arrest [47]. Immunoblots with the appropriate antibodies showed that 
treatment with CM significantly induced p21WAF independently from TNFα (Figure 
4B; compare lanes 1-2 with 3-4) while pERKs expression was inhibited in CM treated 
cells, strongly supporting the antiproliferative effect of molecule(s) present in L. gasseri 
supernatant.  
Altogether these experiments clearly indicate that L. gasseri supernatant exerts a 
cytostatic but not a cytotoxic effect on epithelial colon cells.  
 
1.3.4 The CM of L. gasseri SF1183 protects HCT116 cells from cisplatin induced 
apoptosis. To test whether bioactive molecules present in L. gasseri supernatant could 
exert anti-apoptotic effects against other apoptosis-inducers we preincubated HCT116 
cells with CM and then treated them with 30 µM cisplatin to induce the intrinsic 
apoptotic pathway. As shown in Figure 5A cytofluorimetric analysis indicate that a G1 
cell cycle arrest is induced by CM addition which causes cells to be more resistant to 
cisplatin induced apoptosis. These observations are supported, at the molecular level, 
with an increase in p21WAF1 levels and a decrease of ERKs activation when CM was 
added to the cells (Figure 5B, lanes 1,2). Consistently, pretreatment of cells with CM 
determined a reduction in the extent of PARP-1 cleavage when cells were subjected to 
cisplatin action (Figure 5B, lanes 3,4). 
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Altogether our results clearly indicate that probiotic L. gasseri protects intestinal 
epithelial cells from apoptosis induced by inflammatory cytokines or cytotoxic drugs, 
causing cell cycle arrest.  
 
 
Fig. 5 The anti-apoptotic effect of L. gasseri is not specific for TNFα-induced 
apoptosis. Proliferating HCT116 cells were incubated in complete cell culture medium 
supplemented or not with CM (20%v/v) and/or cisplatin (30µM). After the treatments, 
cells were collected and treated for flow-cytometric analysis (A) or western blot (B) 
with the indicated antibodies.  
 
1.4 Conclusions 
The main result of this report is that the conditioned medium of a stationary culture of 
the human isolate SF1183 of L. gasseri contains molecule(s) able to affect cell 
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proliferation of HCT116 cells, protecting them from intrinsic as well as extrinsic, 
TNFα-induced, apoptosis. Chronic inflammations cause an increase in inflammatory 
cytokines (such as TNFα), epithelial cell apoptosis and immune cell infiltration, leading 
to disruption of the intestinal epithelial integrity. Therefore, a reduction of cell 
proliferation could protect epithelial barrier integrity and help in reconstituting tissutal 
homeostasis.  
The L. gasseri molecule(s) responsible of the observed effects is proteinaceous, has a 
small (less than 3 kDa) size and its synthesis is growth phase-dependent, occuring only 
in bacterial cells in stationary phase. Those properties are suggestive of bacterial 
quorum-sensing autoinducers, communication molecules produced at high cell density 
and known to act as modulator of bacterial host responses [31,32,33]. Unfortunately, the 
definition of the chemical nature of the molecule(s) secreted by L. gasseri SF1183 and 
able to affect HCT116 cells has been so far unsuccessful. The size-fractionated (less 
than 3 kDa) CM of L. gasseri was analyzed by gel filtration chromatography with a 
Superdex Peptide 10/300 GL (GE Healthecare Life Sciences) column and two main 
peaks were obtained (Suppl. Mat Fig. S1). Chromatographic fractions containing either 
one of the two peaks were tested for the ability to reduce the TNFα-induced cleavage of 
PARP-1 (Suppl. Mat Fig. S2A). Only one of the fractions (Fraction 1) was shown to 
reduce the TNFα-induced cleavage of PARP-1 at the same extent of the unfractionated 
CM (Suppl. Mat Fig. S2B). Unfortunately, attempts to analyze Fraction 1 by mass-
spectrometry have been so far unsuccessful, probably because of the minimal 
concentration of molecules in the fraction. To define the chemical nature of the 
molecule(s) affecting HCT116 cells and identify its cellular and molecular targets will 
then be a future and challenging task.  
 
CHAPTER 1 
! 26!
1.5 Materials and Methods 
1.5.1 Bacterial growth and preparation of conditioned medium 
Lactobacillus gasseri (SF1183) was grown in MRS broth (Difco, Detroit, MI) for 24 
hours at 37°C and the culture diluted and used to inoculate MDM (Glucose  10 g/L, 
Sodium acetate  5g/L, KH2PO4  3 g/L, K2HPO4  3 g/L, MgSO4 * 7H2O  0.2 g/L, L-
Alanine 0.10 g/L,  L-Arginine 0.10 g/L,  L-Aspartic acid 0.20 g/L,  L-Cysteine  0.20 
g/L, L-Glutamic 0.20 g/L, L-Histidine 0.10 g/L,  L-Isoleucine 0.10 g/L,  L-Leucine 0.10 
g/L,  L-Lysine 0.10 g/L,  L-Methionine 0.10 g/L,  L-Phenylalanine 0.10 g/L,   L-Serine  
0.10 g/L,L-Tryptophan  0.10 g/L, L-Tyrosine 0.10 g/L,  L-Valine  0.10 g/L, Nicotinic 
acid 0.001 g/L,  Pantothenic acid  0.001 g/L, Pyridoxal  0.002 g/L, Riboflavin  0.001 
g/L, Cyanocobalamin  0.001 g/L, Adenine  0.01 g/L, Guanine 0.01 g/L, Uracil 0.01 g/L) 
minimal medium. Cells of SF1183 were then grown anaerobically for 48 hours at 37°C. 
The culture was centrifuged (3000 rpm for 10 min at RT) and the supernatant 
(conditioned medium, CM) was filtered-sterilized through a 0.22 mm low-protein 
binding filter (Millex; Millipore, Bedford, MA). CM treated with proteases and 
nucleases was prepared as described above and size fractionated (3-kDa cutoff spin 
column; Centricon, Millipore). Before treatment with trypsin (GIBCO) or proteinase K 
(Invitrogen), or DNasi I, or RNasi A (Invitrogen) at a final 100 ug/ml concentration for 
60 min at 37°C the pH of CM was neutralized with concentrated NaOH (10 N). After 
the enzymatic treatments CM was acidified to pH 4.0 using concentrated HCl and 
fractionated as described above to remove the enzymes.  
 
1.5.2 Cell culture and treatment with bacterial CM  
HCT116 cells (ATCC CCL 247) derived from a poorly-differentiated colonic 
adenocarcinoma and were maintained in RPMI 1640 supplemented with 10% fetal 
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bovine serum and 1% penicillin-streptomycin. Cells were cultured at 37°C in 
humidified atmosphere of 5% CO2. The bacterial CM was employed for the treatment at 
20% v/v concentration in complete growth medium. After incubation of 16 hours with 
CM (20% v/v), TNFα (1 nM, Millipore) or Cisplatin (30 µM, Sigma) was added and 
cells harvested after 8 hours or 24 hours of treatment. Cells were lysed and cell extracts 
prepared for Western blot and FACS analysis, respectively, as described below.  
 
1.5.3 SDS-PAGE and Western Immunoblot analysis 
Cells were harvested in lysis buffer (50 mM Tris-HCl pH 7.5, 5 mM EDTA, 150 mM 
NaCl, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, 0.5% sodium deoxycholate, 
and protease inhibitors) and total protein extract prepared as previously described [48]. 
Briefly, cell lysates were incubated on ice for 40 minutes, and the extracts were 
centrifuged at 13200 rpm for 15 minutes to remove cell debris. Protein concentration 
was determined by the Bio-Rad protein assay (Bio-Rad). After the addition of 2x 
Laemmli buffer (SIGMA), samples were boiled at 100°C for 5 minutes and resolved by 
SDS-polyacrylamide gel electrophoresis (10% or 12%). Proteins were transferred to 
polyvinylidenedifluoride (PVDF) membranes (Millipore) as previously described [49]. 
The membranes were blocked in 5% w/v milk buffer (5% w/v non-fat dried milk, 50 
mM Tris, 200 mM NaCl, 0,2% Tween 20) and incubated with primary antibody diluted 
in 5% w/v milk or bovine serum albumine buffer for 2 hours at room temperature or 
overnight at 4°C. Primary antibodies were anti-rabbit PARP-1 (Cell Signalling), anti-
rabbit pErks 42/44 (Cell Signalling), anti-rabbit p21WAF1 (Santa-Cruz Biotechnology), 
anti-goat β-actin (Santa-Cruz Biotechnology). Data were visualized by enhanced 
chemiluminescence method (ECL, GE-Healthcare) using HRP-conjugated secondary 
antibody (Santa-Cruz Biotechnology) incubated 1 hour at room temperature, and 
CHAPTER 1 
! 28!
analysed by Quantity One ®software of ChemiDoc TMXRS system (Bio-Rad). 
 
1.5.4 Cell growth and flow cytometry analysis 
HCT116 cells were plated in 35mm dishes at the cell density of 2,5 x 105 cells/plate. 
For cell growth analysis, cells were cultured in complete growth medium supplemented 
or not with bacterial CM at 20% v/v concentration for 24 hours. After the treatment, 
cells were collected and counted in a Burker chamber. Flow cytometry analysis was 
performed as previously described [50]. Briefly, cells were washed twice with PBS and 
harvested with 0.05% trypsin in 0.15% Na2EDTA. Cells were then centrifuged, washed 
in PBS, fixed with ice-cold 70% ethanol, and stored overnight at 4°C. Fixed cells were 
washed in PBS and then incubated with propidium iodide (50 µg/ml) and RNAse A (10 
µg/ml) for 30 min at room temperature. Data acquisition was performed using a CyAn 
ADP Flow Cytometer (Beckman Coulter, Inc., Milano, Italy) and Summit Software.  
 
1.5.5 MTS assay 
HCT116 cells were cultured at a density of 2,5x105 cells per well in flat bottomed 6-
well plates and supplemented or not with CM (20% v/v) for 24 hours.  After treatment, 
CellTiter 96® AQUEOUS One Solution Reagent (Promega, Madison, WI) was added to 
each well according to the manufacturer’s instructions.  After 30 minutes cell viability 
was determined by measuring the absorbance at 490nm using a Multiskan spectrum 
(Thermo Electron Corporation). 
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1.8 Supporting Information 
 
 
 
Fig. S1. The CM of L. gasseri was size fractionated with a 3 kDa molecular mass cut-
off filter and loaded on a gel filtration chromatographic column (Superdex Peptide 
10/300 GL, GE Healthecare Life Sciences). The elution buffer was AMAC 0.3 M. Two 
main peaks were observed at 220 nm. 
 
 
 
 
Fig. S2. Chromatographic fractions from the experiment of Fig. S1 were tested by 
western blotting with anti-PARP-1 antibody (A). As a control, cells were also treated 
with the elution buffer (AMAC 0,3 M). (B) Densitometric analysis of the western blot. 
PARP-1 band intensity was evaluated by ImageQuant analysis on at least two different 
expositions to assure the linearity of each acquisition. Values are expressed as ratio 
with the corresponding actin values and normalised to the reference point (PARP-1 
cleavage in medium). Percentage of increase (+) or decrease (—) with respect to the 
intensity of the reference point are indicated. 
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Fig. S3. Enlargment of part of Fig. 4 showing the output of the FACS analysis. 
 
 
 
Fig. S4. Enlargment of part of Fig. 5 showing the output of the FACS analysis. 
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2.1 Abstract 
 
Bacteria use quorum-sensing molecules to communicate within and across species. In 
this regulatory system an inducing molecule is secreted during growth, accumulates 
outside the cell and is then sensed by the producing organism, as well as by other cells 
that respond to the signal expressing specific sets of genes. Quorum-sensing molecules 
are also recognized by eukaryotic cells and examples are: i) a molecule produced by 
Pseudomonas aeruginosa shown to activate the p38 mitogen-activated protein kinase 
and phosphorilate the eukaryotic translation initiation factor eIF2a in macrophages and 
bronchial epithelial cells and ii) the Bacillus subtilis pentapeptide, known as CSF 
(competence and sporulation factor) shown to induce cytoprotective heat shock proteins 
(HSPs) and prevent oxidant-induced intestinal epithelial cell injury. We developed a 
genetic system to evaluate the presence of CSF in bacterial conditioned growth media 
and used it to screen a collection of intestinal isolates of B. subtilis. Most isolates 
produced high amounts of CSF and some of them were able to do that also in anaerobic 
growth conditions. The conditioned medium of all CSF-producing strains was able to 
induce Hsp27 while only one strain not producing CSF was still able to induce Hsp27. 
A proteomic approach was used to investigate the molecular mechanisms underlying 
this induced-cytoprotective effect. Total protein extracts of HT29 cells treated and not-
treated with CSF were analysed by 2D-PAGE-MS/MS to identify proteins up- or down-
regulated in the treated sample. 
 
2.2 Introduction 
 
The gastrointestinal tract (GIT) is the site of the largest and most complex environment 
in the mammalian host. In the adult human, the total microbial population (ca. 10^14 
cells) is estimated to exceed the total number of mammalian cells by at least an order of 
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magnitude (Berg RD, 1996). The GIT features several diverse “macro” environments, 
including the oral cavity, the stomach, the small intestine (including the three major 
regions, the duodenum, jejunum, and ileum), and the large intestine (colon). The density 
of bacteria along the GI tract can vary greatly, from 10^3/ml near the gastric outlet to 
10^10/ml at the ileo-cecal valve to 10^11 to 10^12/ml in the colon (Borrellio SP, 2002). 
Within these “macro” environments are several “micro” environments where bacteria 
can live, such as the lumen of the bowel, the mucus layer overlying the epithelium, 
mucus within intestinal crypts, and the surface of mucosal epithelial cells. Given the 
enormous number and diversity of bacteria that comprise the GI environment, it would 
not be surprising if the members of this community were to somehow communicate 
among themselves to coordinate various processes ranging from maintenance of the 
commensal population to aiding or resisting infectious diseases (Kaper JB and 
Sperandio V, 2005). Over the last decade an important paradigm shift has been our 
changing perspective of bacteria as unicellular and non-co-operative to socially 
interactive and capable of multicellular behavior. Bacteria are clearly capable of 
complex patterns of co-operative behavior that result from the coordination of the 
activities of individual cells. This is primarily achieved through the deployment of small 
diffusible signal molecules (sometimes called ‘pheromones’ or ‘autoinducers’) which 
are generally considered to facilitate the regulation of gene expression as a function of 
cell population density. This phenomenon is termed ‘quorum sensing’ (QS). As the 
bacterial population density increases, so does the synthesis of QS signal molecules and 
consequently, their concentration in the external environment rises. Once a threshold 
concentration has been attained, activation of a signal transduction cascade leads to the 
induction or repression of QS target genes, often incorporating those required for QS 
signal molecule synthesis, so providing an auto-regulatory mechanism for amplifying 
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signal molecule production. Consequently, the size of the ‘quorum’ is not fixed but will 
depend on the relative rates of production and loss of the signal molecule, which will, in 
turn, vary depending on the local environmental conditions (Williams P, 2007). In 
general QS systems facilitate the coordination of population behavior to enhance access 
to nutrients or specific environmental niches, collective defense against other 
competitor organisms or community escape where survival of the population is 
threatened. Although QS has primarily been studied in the context of single species, the 
expression of QS systems may be manipulated by the activities of other bacteria within 
complex microbial consortia which employ different QS signals and by higher 
organisms.  
Three major QS circuits have been described: one is used primarily by gram-negative 
bacteria, one is used primarily by gram-positive bacteria, and one has been proposed to 
be a hybrid system. The gram-negative QS system involves the use of acyl homoserine 
lactones (AHLs) as autoinducers, which then bind to response regulators that affect 
gene expression. The gram positive bacteria use oligopeptide autoinducers that are 
detected by two-component systems. The third QS system is proposed to be a hybrid 
system because it is characterized by autoinducers very similar to ones used by gram-
negative, but these molecules activate a signal cascades in target cells that is generally 
found in gram-positive. Moreover, QS signal molecules can also be subdivided 
according to whether they interact with receptors at the cell surface (e.g. the 
staphylococcal AIPs) or are internalized (e.g. the AHLs, AQs, the Phr peptides of 
Bacillus subtilis and the mating pheromones of Enterococcus faecalis).  
In a typical gram-negative bacterial quorum-sensing circuit the autoinducer is an 
acylated homoserine lactone (AHL) synthesized by a LuxI-type enzyme. 
Cytoplasmically synthesized autoinducer diffuses passively through the bacterial 
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membrane and accumulates both intra- and extracellularly in proportion to cell density. 
When the stimulatory concentration of the AHL is achieved, a LuxR-type protein binds 
it. LuxR-AHL complexes bind to promoters of quorum sensing-regulated target genes 
and activate transcription. Over 50 species of gram- negative bacteria produce AHLs 
that differ only in the acyl side chain moiety, and each LuxR-type protein is highly 
selective for its cognate AHL signal molecule. Additional complexity exists in many of 
these circuits, such as the use of multiple AHL autoinducers and LuxR proteins that can 
act either in parallel or in series. 
In the quorum sensing circuit of a gram-positive bacterium the autoinducers are short, 
usually modified peptides processed from precursors. The signals are actively exported 
out of the cell, and they interact with the external domains of membrane bound sensor 
proteins. Signal transduction occurs by a phosphorylation cascade that culminates in the 
activation of a DNA binding protein that controls transcription of target genes. 
Specificity exists because each sensor protein is highly selective for a given peptide 
signal. Similar to gram-negative bacteria, gram-positive bacteria can use multiple 
autoinducers and sensors. Some peptide autoinducers act exclusively from the outside, 
while others elicit a specific set of gene expression changes from the outside and are 
also transported back into the cell where they trigger a different set of behavioral 
changes.  
The third model system is studied in gram-negative bacterium Vibrio harveyi. This 
quorum sensing circuit controls bioluminescence. V. harveyi produces two autoinducers 
termed HAI-1 and AI-2. HAI-1 is a typical gram-negative-like AHL and the second 
autoinducer, AI-2, is unexpectedly a furanosyl borate diester. HAI-1 and AI-2 signal 
transduction occurs via a gram-positive-like phosphorylation cascade (Bassler BL, 
2002).  
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While the quorum sensing systems involved in bacterial communication are well-know, 
the mechanism(s) by which different bacteria (pathogens and/or probiotics) exert their 
effects in a cross-kingdom quorum-sensing system is not clearly understood. As well as 
promoting pathogen success, certain QS signal molecules exert beneficial effects on the 
host. Although the mechanism(s) used by probiotic bacteria, such as certain bacilli and 
lactobacilli, to exert protective effects in the gastro-intestinal tract is not clear, it is 
likely to involve pathogen control or exclusion as well as protection of host tissues 
against inflammatory responses. Interestingly, among probiotics it’s known that the 
Bacillus subtilis strain has a protective effect on the host that involves a pentapeptide 
QS signal molecule, the competence and sporulating factor, CSF (also called PhrC). 
In Bacillus subtilis, sporulation and the development of genetic competence (the natural 
ability to import exogenous DNA) are stimulated as cells grow to high cell density. As 
with other gram-positive bacteria, cell density control in B. subtilis is mediated by 
extracellular peptides (Lazzazzera BA and Grossmann AD, 1998). The development of 
genetic competence is stimulated by two peptide factors, ComX pheromone, a modified 
10-aminoacid peptide (Magnuson R., el al. 1994), and the competence and sporulation 
factor (CSF), an unmodified five-aminoacid peptide (Solomon JM, et al. 1996). ComX 
pheromone and CSF stimulate transcription of the srfA operon which encodes a small 
protein ComS required for competence development (D’Souza C., et al. 1994), and the 
surfactin biosynthetic enzymes (Nakano MM, et al. 1991). Transcription from the srfA 
promoter is activated by the phosphorylated form of the response regulator ComA 
(Nakano MM and Zuber P., 1991), and activity of ComA is controlled by a kinase, 
ComP, and a phosphatase, RapC. ComP, a membrane-bound histidine protein kinase, is 
required for activation of ComA while RapC, a putative aspartyl-phosphate 
phosphatase, inhibits activation of ComA. ComX pheromone, whose active form 
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production needs ComQ, stimulates gene expression, apparently by stimulating the 
kinase ComP, whereas CSF stimulates gene expression, apparently by inhibiting the 
phosphatase RapC. ComX pheromone most likely works at the cell surface, and CSF is 
actively transported into the cell by the oligopeptide permease Opp (also known as 
Spo0K), where it interacts with intracellular receptors. Furthermore, σH, the spo0H gene 
product, activates transcription of phrC. Transcription of phrC was found to be 
controlled by two promoters: P1, which precedes rapC, the gene upstream of phrC; and 
P2, which directs transcription of phrC only. Both RapC and CSF were found to be part 
of autoregulatory loops that affect transcription from P1, which is activated by 
ComA∼P. RapC negatively regulates its own expression, presumably due to its ability 
to inhibit accumulation of ComA∼P. CSF positively regulates its own expression, 
presumably due to its ability to inhibit RapC activity. Transcription from P2, which is 
controlled by the alternate sigma factor σH, increased as cells entered stationary phase, 
contributing to the increase in extracellular CSF at this time. In addition to controlling 
transcription of phrC, σH appears to control expression of at least one other gene 
required for production of CSF. 
CSF has a remarkable constellation of activities for a five amino- acid peptide. At 
relatively low extracellular concentrations (1 to 5 nM), CSF stimulates expression of 
srfA by inhibiting the phosphatase RapC. However, high concentrations of CSF (> 20 
nM) inhibit expression of srfA, perhaps by inhibiting activity of the kinase ComP. In 
addition to its effects on expression of ComA∼P-controlled genes, high concentrations 
of CSF (>20 nM) can stimulate sporulation under some conditions (Lazzazera BA., et 
al. 1997). CSF appears to stimulate sporulation, at least in part, by inhibiting the activity 
of the phosphatase RapB, an aspartyl-phosphate phosphatase that dephosphorylates 
Spo0F∼P, an essential component of the phosphorelay that controls sporulation. 
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Production of mature CSF involves several steps, starting with transcription and 
translation of phrC, the gene encoding the precursor of CSF. The 40-amino-acid 
primary product of phrC has a signal sequence and putative peptidase cleavage sites, 
indicating that a 11- to 25-amino-acid peptide is exported via a Sec-dependent pathway. 
Pre-CSF is then processed to the mature five-amino-acid form. It seems likely that there 
is a specific peptidase that recognizes and cleaves pre-CSF. Such a peptidase would be 
a good candidate for a σH -controlled gene product required for CSF production. 
(Lazzazzera BA., et al 1999). 
Interestingly, in a cross-kingdom quorum-sensing system CSF induces the expression of 
heat-shock-inducible protein 27 (Hsp27) in the human colonic epithelial cell line Caco2 
and in ligated mouse intestinal loops (Fujiya et al., 2007). Hsps confer protection 
against a wide variety of stresses and, when overexpressed, can protect intestinal 
epithelial cells from oxidative injury and so contribute to the maintenance of intestinal 
homeostasis. Intestinal epithelia express many heat shock proteins, including inducible 
Hsp27(human)/Hsp25(murine) and Hsp70 and constitutively expressed heat shock 
cognate Hsc70. The nomenclature, Hsp27 and Hsp25, defines the related small heat 
shock proteins of approximate molecular weight of 27 kDa and 25 kDa of human and 
murine cells, respectively (Morimoto, 1993 and Morimoto, 2002). Physiological 
expression of inducible heat shock proteins like Hsp27/25 and Hsp70 is maintained by 
microbial-derived molecules, including pattern recognition ligands (Rakoff-Nahoum et 
al., 2004), accounting for their predominant expression in surface colonocytes.  
In this contest, the biological activity of CSF is within the concentration range required 
for QS in B. subtilis (10–100 nM), an important consideration given that some of 
observed activities of QS molecules on mammalian cells are only apparent at high, non-
physiological concentrations (Pritchard, 2006). Fujiya et al. (2007) also identified a 
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mammalian apical membrane oligopeptide transporter (OCTN2) which is required for 
CSF uptake. CSF and OCTN2-mediated CSF transport are both required to protect 
Caco2 cells against oxidant- mediated injury and loss of epithelial barrier function.  
Here, we investigated about the efficiency of B. subtilis spp. isolated from ileum of 
healthy-human volunteers, to produce and secrete CSF and thus, to induce Hsp27 in 
human intestinal epithelial cell line HT29. Moreover, we used a proteomic approach to 
identify other CSF targets. !
2.3 Results 
2.3.1 CSF-production by intestinal isolates of Bacillus subtilis 
The conditioned medium (CM) of various intestinal isolates of Bacillus subtilis (Fakhry 
S., et al. 2008) was analyzed to detect the presence of CSF. As an assay we followed the 
production of beta-galactosidase activity of an engineerized strain of B. subtilis carrying 
the CSF-inducible promoter sfrA fused to lacZ in a comQ-phrC null background. In this 
strain CSF is not produced and the β-gal activity can be induced by exogenous CSF. In 
Fig. 1, it’s shown that all the intestinal isolates, but two (SF185, SF155) were able to 
produce and secrete the bioactive pentapeptide. Five strains (SFB2, SF106, SF195, 
SF151, SF154) produced higher CSF amounts and three strains (SF128, SF152 and 
SF153) lower CSF amounts than the laboratory strain PY79 (Fig. 1). The same assay 
was also performed to evaluate if these isolates were able to produce the CSF in 
anaerobic condition of growth. Strains SFB2, SF106, SF151, SF152, SF154 and SF195 
were able to grow anaerobically and produce CSF (not shown). 
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Fig. 1. Beta-galactosidase production in response to aerobically produced CSF. β-
galactosidase activity (Miller units) induced by cell-free supernatants of the various 
strains to the recipient strain (srfA::lacZ comQ phrC). Black bars correspond to the 
laboratory strain PY79 (positive control) and the isogenic mutant PY79 ΔphrC 
(negative control). Purple bars indicate the intestinal isolates producing much more 
CSF than the laboratory strain PY79; blue bars indicate the intestinal isolates 
producing less CSF than the laboratory strain PY79; green bars indicate the intestinal 
isolates that do not produce CSF. 
 
2.3.2 CSF- induction of heat shock protein 27 (hsp27) by isolates of Bacillus 
subtilis in HT29 intestinal epithelial cells. 
The conditioned medium of all strains used for the experiment of Fig. 1 was also tested 
for the ability to induce heat shock in human colon adenocarcinoma HT29 cells. It’s 
well-known that CSF, produced by Bacillus subtilis laboratory strain, is able to induce 
Hsp27 in Caco2bbe intestinal epithelial cells, in a dose-dependent fashion and that it’s 
transported into mammalian intestinal epithelia through a cell membrane transporter 
isotype 2 (OCTN2) (Fujiya et al., 2007). Firstly, we observed the same induction of 
hsp27 in HT29 intestinal cell line by adding to the colture PY79 CM and the synthetic 
CSF peptide (ERGMT) as shown in Fig 2A. The isogenic mutant PY79 ΔphrC is not 
able to produce CSF and so its CM does not induce Hsp27. As expected all CMs 
positive to the test of Fig. 1 were also able to induce Hsp27 to levels similar to those 
observed with PY79 and after heat shock (Fig. 2B). 
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Fig.2 Heat shock protein 27 (Hsp27) induction in HT29 intestinal epithelial cells. (A) 
Conditioned-medium (20% v/v) of laboratory strain of Bacillus subtilis (PY79) induces 
Hsp27 in HT29 intestinal epithelial cells as well as the syntethic CSF (100 nM) and the 
heat-shocked control sample (30min at 45°C). (B) All intestinal isolates of Bacillus 
subtilis, positive to β-galactosidase assay, are able to induce Hsp27 in HT29 cells. (C) 
The supernatants of isogenic ComQ-phrC null mutant strains lost their biological 
activity, as expected.! After the treatments cells were collected, lysed and protein 
concentration determined. Equal amount of cell lysates were fractionated on SDS-
PAGE and analyzed by western blotting with antibodies against Hsp27. Actin was used 
as a loading control. 
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To verify that HSP induction was due to CSF we obtained by chromosomal DNA 
mediated transformation phrC null mutants of the intestinal strains and tested them for 
HSP induction (Fig. 2C). 
 
2.3.3 Analysis of phrC gene in SF185 strain and preliminary characterization of 
active molecule secreted inducing Hsp27 in HT29 cells. 
SF155 and SF185 are intestinal isolates of B. subtilis unable to produce CSF (Fig. 1). 
However, when tested for HSP induction, only SF185 was able to induce Hsp27 in 
HT29 (Fig. 3). To rule out the possibility that SF185 produces CSF at very low levels, 
too low to activate srfA::lacZ (Fig. 1) but enough to induce HSP (Fig. 3) we analyzed 
the strain for the presence and expression of CSF.  
 
Fig.3 SF185 and SF155 strains not-producing CSF are tested for hsp27 induction in 
intestinal epithelial cells (HT29). The panel clearly shows the induction hsp27 after 
stimulation of HT29 cells with conditioned media of SF185 and SF155 strains. After the 
treatments cells were collected, lysed and protein concentration determined. Equal 
amount of cell lysates were fractionated on SDS-PAGE and analyzed by western 
blotting with antibodies against hsp27. Actin was used as a loading control. 
 
A PCR analysis showed that both SF155 and SF185 have a copy of phrC gene in their 
genome (Fig. 4A) while a semi-quantitative RT-PCR analysis showed that phrC of both 
strains is not expressed (Fig. 4B). However, this result does not totally exclude the 
possibility that phrC is weakly transcribed (below the RT-PCR resolution limit). 
Therefore, we moved by chromosomal DNA mediated transformation the phrC-null 
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carried by the laboratory collection strain into SF185. CM of the resulting strain was 
still able to induce Hsp27 in HT29 cells (Fig. 4C). Results of Fig. 4A-B-C then indicate 
that a molecule other than CSF is produced and secreted by SF185 and is able to induce 
HSP in HT29 cells. 
 
 
 
 
Fig.4 SF185 strain. PCR (A) and RT-PCR (B) analysis of the phrC locus in various 
intestinal isolates. (C) HSP induction with CM of SF185 and of its isogenic phrC null 
mutant. Panel on the right reports the densitometric analysis of the western blot shown 
on the left. (D) Biochemical characterization of the CM of SF185. 
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A preliminary characterization of this molecule has been made. As shown in Fig. 4D, 
the conditioned-medium was size-separated by using a 3 kDa molecular mass cut-off 
filter and the bioactivity was still observed in the lower fraction suggesting a small 
molecular mass for the effector molecule. Moreover, the supernatant was also treated 
with the proteinase- K (see Materials and Methods) and when added to HT29 cell 
culture after the enzymatic treatment, it was unable to induce HSP, suggesting its 
proteinaceous nature. Further characterization of the molecule by mass-spectrometry 
analysis is currently in progress. 
 
2.3.4 Analysis of proteome changes in HT29 cells treated with synthetic CSF 
(100nM). 
Although CSF is known to induce Hsp27 and to stimulate the phosphorilation of Akt 
and p38 MAPK, two additional survival pathway of intestinal epithelial cells (Fujiya et 
al., 2007), it’s not yet clear the molecular mechanisms by which it affects cellular 
methabolism. We thus decided to look at cell proteome changes of HT29 treated with 
CSF (100nM). Protein extracts from untreated (Control, NT) or CSF-treated (CSF) 
HT29 cells were fractionated by 2D-GE and stained with colloidal Blue Coomassie (fig. 
5). The gels were run in triplicate and compared using the ImageMaster 2D Platinum 
6.0 software. A few initial reference points (landmarks) were affixed for gels alignment 
in the first step of the images analysis. The spots were detected on the gels and the 
software ‘matched’ the gels and the corresponding spots. The different 2DE images 
were compared by synchronized 3-D spots view. Among the spots corresponding to 
CSF-sensitive proteins clearly detected in repeated trials, 24 were selected for 
proteomic analysis. The image analysis enabled the identification of 15 spots that were 
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present either in higher or lower amount in the CSF-treated sample, thereby indicating 
that they were induced by the treatment.  
 
Fig.5 2D-GE of cell lysates of not-treated (control, NT) and CSF-treated HT29. 
Panels show different amounts and separation of not-treated and CSF-treated HT29 
total proteic extract. The spots that showed a different trend (increase/decrease or 
present/absent) in the two analyzed samples were then selected for mass spectral 
identification. 
 
These spots were selected for mass spectral identification by the merging of images 
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with trypsin. The resulting peptide mixtures were analysed by nanoLC/MS/MS 
experiments. The peptide mixtures were fractionated by nanoHPLC and sequenced by 
MS/MS, generating sequence information on individual peptides. MSMS spectra were 
used to search for a non-redundant sequence using the in-house MASCOT software, 
thus taking advantage of the specificity of trypsin and of the taxonomic category of the 
samples. The number of measured masses that matched within the given mass accuracy 
was recorded, and the proteins that had the highest number of peptide matches were 
examined leading to the identification of the protein components. As further selection 
criteria, only the proteins, identified by MASCOT search with at least two peptides and 
found exclusively in the replicates, were selected. The list of proteins identified by this 
approach is illustrated in Table 1. Among the identified proteins, the signal 
corresponding to enolase-1 showed a decrease in the treated sample as well as that of 
phosphoglycerate kinase 1 (PGK1) while the signal corresponding to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) showed an increment. All these enzymes are 
involved in the glycolytic methabolism and more precisely, PGK1 and enolase-1 
catalyze the sixth and eighth reactions of the pathway, respectively, while GADPH is 
immediately upstream (fifth reaction). Interestingly, although the increase of GADPH, 
the downstream enzymes didn’t show the same trend suggesting that, in this condition, 
GADPH is involved in other mechanism besides the primary metabolism. Validation of 
proteomic data by western blot is currently in progress.  
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Table 1 List of proteins differentially represented in CSF-treated or control HT29 cells 
identified by mass spectrometry. 
 
Spot Protein CSF/Ctr 
1 GAPDH + 
2 GAPDH; Annexin A2 + 
3 Annexin A2 + 
4 HNRNPK; HSPA8 + 
5 HSP60 + 
6 Keratin-8 - 
7 Tubulin beta-4B chain + 
8 Keratin-18 + 
9 Actin; SERPINB1; CCT2 - 
10 Actin; PGK1; SERPINB1 - 
11 PGK1 - 
12 Keratin-20 - 
13 Enolase 1 - 
14 HSPB1 + 
15 NPM1; C protein - 
 
2.4 Discussion 
Although the gram positive Bacillus subtilis is commonly found in soil, more recent 
evidence suggests that it inhabits the GIT and should be considered as a normal gut 
commensal (Hong, et al., 2009; Fakhry et al., 2008). Moreover, a laboratory strain of B. 
subtilis (PY79) is known to produce and secrete a bioactive pentapeptide (CSF), 
generally involved in the gram-positive quorum-sensing mechanism, that exerts 
cytoprotective effects on intestinal epithelial cells inducing the heat-shock protein 27, as 
described before (Fujiya et al., 2007). However, the molecular mechanisms underlying 
this cross-kingdom quorum-sensing and the associated effects are not yet well-
understood. Starting from all these evidences, this study reports a characterization of 
Bacillus subtilis spp, isolated from human intestinal biopsies, with the purpose to 
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investigate the induced metabolic changes on intestinal epithelial cells (HT29), using a 
molecular approach. Focusing on their capacity to produce and secrete the CSF and thus 
to exert cytoprotective effects, it is observed that all the strains, positive for the 
production of the pentapeptide, are also able to induce the hsp27 in HT29 cell-line, as 
expected. Interestingly, strain SF185 that does not produce CSF is still able to induce 
Hsp27. PCR and RT-PCR analyses showed that the gene is present but not expressed, 
suggesting that SF185 is able to produce and secrete another bioactive molecule 
different from CSF but exerting very similar functions on epithelial cells. A preliminary 
characterization of this secreted factor shows that it is smaller than 3kDa and has a 
proteinaceus nature. To define the chemical nature of this molecule affecting intestinal 
epithelial cells and identify its cellular and molecular targets is a challenging task, 
actually in progress.  
We also focused on the study of metabolic changes induced by CSF stimulation, using a 
proteomic approach. Interestingly, the MS/MS analysis performed on cell lysates of 
treated and not-treated HT29 shows changes in the amount of enzymes involved in the 
glycolitic methabolism. More precisely, it’s observed an increase in GADPH levels and 
a related decrease in phosphoglycerate kinase 1 (PGK1) and enolase-1 in the treated 
sample compared to the not-treated. Since PGK1 and enolase-1 catalyze the sixth and 
eighth reactions of the pathway, respectively, and GADPH is immediately upstream 
(fifth reaction), these results suggest that GAPDH could have other fuctions other than 
being part of the glycolytic pathway. Recent studies showed that an increase in GAPDH 
levels, but not in PGK1 or enolase-1 levels, protects cells from cell-death (Jaquin et al., 
2013). In addition, when overexpressed GAPDH binds to active Akt limiting its 
dephosphorylation (Jaquin et al., 2013). Phosphorylated-Akt increase leads to Bcl-xL 
overexpression that is able to protect a subset of mitochondria from permeabilization 
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that are required for cellular survival from caspase-independent cell death (CICD). 
Moreover, in CSF-treated sample we also observed a concomitant increase of Hsp60, a 
known mitochondrial heat-shock protein involved in apoptosis regulation, indirectly 
supporting the pro-proliferative role of CSF. Recent studies have suggested that Hsp60 
also occurs in the cytosol and plays a key role in preventing apoptosis (Kurt et al., 2000; 
Ghosh et al., 2007). Experiments are in progress to validate MS/MS results by western 
blot and to clarify the involvement of these stress-response proteins in the pro-survival 
mechanism activated by CSF in epithelial cells. In particular, vitality assays (MTS) and 
cytofluorimetric analyses are in progress to check if primary methabolism and cell-
cycle regulation are affected as well. 
 
2.5 Materials and Methods 
2.5.1 Construction of the reporter strain ED5 
Chromosomal DNA from strain JH11300 (carrying a functional phrC::Cmr gene fusion) 
BD2876 (carrying a functional sfrA::lacZ (Tetr ) gene fusion) B. subtilis were isolated 
as described elsewhere (Cutting S, Vander Horn PB 1990) and were used to transform 
competent cells of laboratory strain PY79, yielding strain ED1 and ED2 respectively. 
Then, the chromosomal DNA from strain BD2876 was also used to transform 
competent cells of ED2 (sfrA::lacZ (Tetr )) to yield isogenic ED4 strain carrying another 
functional gene fusion comQ::Kanr. Finally, the chromosomal DNA of ED1 
(phrC::Cmr) strain was used to transform ED4 competent cells to yield ED5 strain 
(phrC::Cmr, comQ::Kanr, sfrA::lacZ (Tetr )). 
 
2.5.2 PCR and RT-PCR of phrC gene 
The primers for phrC gene amplification were designed using the bioinformatic tool 
Primer3web version 4.0.0 (http://primer3.ut.ee/): phrC For 5’-
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TGAAATTGAAATCTAAGTTGTTTGTT-3’ and phrC Rev 5’- 
ACATGAAAGTCGAGTGCTTCC-3’. They amplified a 100bp fragment of phrC gene 
corresponding from position 2 to 101 of phrC gene of Bacillus subtilis. PCR was 
performed using 100ng of chromosomal DNA of SF185, SF155, SF106 and wild-type 
strain PY79 as template and the following condition of reaction: 5minutes at 95°C and 
30 cycles including 30seconds at 95°C, and 30 seconds at 52°C and 20 seconds at 72°C. 
The PCR products were analyzed and checked for their length on 2% agarose gel with 
ethidium-bromide staining.  
Total RNA was extracted from the isolated strains SF185, SF155, SF106 and the wild-
type strain PY79 using the Qiagen minikit (Qiagen, Milan, Italy) according to the 
manufacturer’s instructions. Total RNAs were dissolved in 50 µl of RNase-free water 
and stored at -80°C. The final concentration and quality of the RNA samples were 
estimated spectrophotometrically and by agarose gel electrophoresis with ethidium 
bromide staining. Total RNAs were treated with RNase free DNase (1 U/µg of total 
RNA; Fermentas) for 30 min at 37°C, and the reaction was stopped with DNase 
inactivation reagent. For reverse transcription-PCR (RT-PCR) analysis a sample 
containing 2 µg of DNase-treated RNA was incubated with phrC Rev at 65°C for 5 min 
and slowly cooled to room temperature to allow the primer annealing. The mixture was 
incubated at 50°C for 1 h in the presence of 1 µl AffinityScript multiple-temperature 
reverse transcriptase (Stratagene), 4 mM dNTPs, reaction buffer (Stratagene), and 10 
mM dithiothreitol (DTT). The enzyme was inactivated at 70°C for 15 min. One-tenth of 
the reaction mix was used as a template in PCRs using oligonucleotide phrC For and 
Rev. The PCR products were analyzed on on 2% agarose gel with ethidium-bromide 
staining. For a control, PCRs were carried out with RNA alone to exclude the 
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possibility that the amplification products could derive from contaminating genomic 
DNA. 
 
2.5.3 Bacterial growth and preparation of conditioned medium 
Intestinal isolates of Bacillus subtilis spp (Fakhry S. et al., 2008) were grown in LB 
broth (for 1 l: 10 g Bacto-Tryptone, 5 g Bacto-yeast extract, 10 g NaCl, pH 7.0) to reach 
0.6- 0.8 OD600nm at 37°C in aerobic condition and the culture diluted and used to 
inoculate minimal S7 medium (50mM MOPS, 10mM (NH4)2SO4, 5mM  potassium 
phosphate pH 7.0, 2mM MgCl2 , 0.9 mM CaCl2 ,50 µM MnCl2, 10 µM ZnCl2, 5 µM 
FeCl3, 2 µM thiamine hydrochloride, 20mM sodium glutamate, 1% glucose, 0.1 mg/ml 
phenylalanine, 0.1 mg/ml tryptophan). Cells were then grown aerobically for 16 hours 
at 37°C. The culture was centrifuged (3000 rpm for 10 min at RT) and the supernatant 
(conditioned medium, CM) was filtered-sterilized through a 0.22 µm low-protein 
binding filter (Millex; Millipore, Bedford, MA). The SF185 CM was size fractionated 
(3-kDa cutoff spin column; Centricon, Millipore) and treated with proteinase-K 
(Invitrogen) at a final 100 ug/ml concentration for 60 min at 37°C. After the enzymatic 
treatments CM was fractionated as described to remove the enzymes. For the 
preparation of conditioned medium in anaerobic conditions, intestinal isolates of 
Bacillus subtilis spp were grown anaerobically in LB broth (for 1 l: 10 g Bacto-
Tryptone, 5 g Bacto-yeast extract, 10 g NaCl, pH 7.0) at 37°C and then used to 
inoculate Difco-Sporulation-inducing (DS) medium. Cells were grown in anaerobic 
conditions for 72 hours at 37°C. 
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2.5.4 Cell culture and treatment with bacterial CM  
HT29 cells (ATCC HTB-38) derived from a poorly-differentiated colonic 
adenocarcinoma and were maintained in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin. 
Cells were cultured at 37°C in humidified atmosphere of 5% CO2. The bacterial CMs 
were employed for the treatment at 20% v/v concentration in complete growth medium. 
After incubation of 24 hours with CM (20% v/v) or synthetic CSF (100 nM, PRIMM 
srl, Milan, IT) cells were harvested, lysed and cell extracts prepared for Western blot 
analysis, as described below.  
 
2.5.5 SDS-PAGE and Western Immunoblot analysis 
Cells were harvested in lysis buffer (50 mM Tris-HCl pH 7.5, 5 mM EDTA, 150 mM 
NaCl, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, 0.5% sodium deoxycholate, 
and protease inhibitors) and total protein extracts prepared. Briefly, cell lysates were 
incubated on ice for 40 minutes, and the extracts were centrifuged at 13200 rpm for 15 
minutes to remove cell debris. Protein concentration was determined by the Bio-Rad 
protein assay (Bio-Rad). After the addition of 2x Laemmli buffer (SIGMA), samples 
were boiled at 100°C for 5 minutes and resolved by SDS-polyacrylamide gel 
electrophoresis (10% or 12%). Proteins were transferred to polyvinylidenedifluoride 
(PVDF) membranes (Millipore). The membranes were blocked in 5% w/v milk buffer 
(5% w/v non-fat dried milk, 50 mM Tris, 200 mM NaCl, 0,2% Tween 20) and 
incubated with primary antibody diluted in 5% w/v milk or bovine serum albumine 
buffer for 2 hours at room temperature or overnight at 4°C. Primary antibodies were 
anti-mouse Hsp27 (Cell Signalling), anti-rabbit β-actin (Santa-Cruz Biotechnology). 
Data were visualized by enhanced chemiluminescence method (ECL, GE-Healthcare) 
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using HRP-conjugated secondary antibody (Santa-Cruz Biotechnology) incubated 1 
hour at room temperature, and analysed by Quantity One ®software of ChemiDoc 
TMXRS system (Bio-Rad). Hsp27 band intensity was evaluated by ImageQuant analysis 
on at least two different expositions to assure the linearity of each acquisition. Values 
expressed as ratio with the corresponding actin values and normalized to the reference 
point (not-treated, NT). 
 
2.5.6 Beta-galactosidase assay 
ComQ-phrC null mutant (ED5) cells were inoculated in isolated Bacillus subtilis 
conditioned media and incubated at 37°C in aerobic conditions until stationary phase of 
growth. 1ml of these cultures was harvested and centrifuged at 4000 rpm for 5minutes 
and the pellet frozen at -80°C. Then, the pellets were resuspended in 1 ml of buffer Z 
(0.06 M Na2HPO4, 0.04 M NaH2PO4, 0.01 M KCl, 0.001 M MgSO4 and 0.05M β-
mercaptoethanol) and 10 ul of toluene were added. After a brief mixing with vortex, the 
tubes were incubated for 5 minutes in a 30°C waterbath. Then, the reaction was started 
by adding 0.2 ml of ONPG solution (0.4 mg/ml ONPG in Z buffer without β-
mercaptoethanol). The tubes were mixed and incubated at 30°C until the color at A420nm 
is approximately 0.3 (clearly yellow). The reaction was stopped by adding 0.5 ml of 
Na2CO3 (1M) and the reaction time was recorded. The tubes were centrifuged for 
5minutes and read A420nm and OD550nm immediately. The activity of β-galactosidase was 
calculated using the following formula: β-galactosidase (Miller units) = ((A420nm – (1.75 
x OD550nm)/ (reaction time (min) x OD595nm)) x 1000. 
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2.5.7 Two-dimensional electrophoresis (2DE).  
The first dimensional electrophoresis (isoelectric focusing, IEF) was carried out on non-
linear wide-range immobilized pH gradients (pH 4–7; 7 cm long IPG strips; GE 
Healthcare, Uppsala, Sweden) and achieved using the Ettan IPGphor system 
(GEHealthcare,Uppsala, Sweden). 200 mg ofprotein extracts was precipitated with 
methanol/chloroform according to (Wessel and Flugge, 1984) and solubilized in 125 ml 
of rehydratation buffer and 0.2% (v/v) carrier ampholyte for 12 h, at 50 mA, at 20°C. 
The strips were then focused according to the following electrical conditions at 20°C: 
500 V for 30 min, 1000 V for 30 min, 5000 V for 10h, until a total of 15000 Vt was 
reached. After focusing, analytical and preparative IPGstrips were equilibrated for 15 
min in 6 M urea, 30% (V/V) glycerol, 2% (w/V) SDS, 0.05 M Tris–HCl, pH 6.8, 1% 
(w/V) dithiothreitol (DTT), and subsequently for 15 min in the same urea/SDS/Tris 
buffer solution but substituting the 1% (w/V) DTT with 2.5% (w/V) iodoacetamide. The 
second dimension was carried out on 12.5% (w/w) polyacrylamide gels (10 cm x 8 cm x 
0.75 mm) at 25 mA/gel constant current and 10°C until the dye front reached the bottom 
of the gel, according to (Laemmli, 1970; Hochstrasser et al., 1988). MS-preparative gels 
were stained overnight with colloidal Coomassie Brilliant Blue and destained with 
MilliQ grade water.  
 
2.5.8 Image analysis.  
Gels images were acquired with an Epson expression 1680 PRO scanner. Computer-
aided 2-D image analysis was carried out using the ImageMasterTM 2D Platinum 
software. Relative spot volumes (%V) (V = integration of OD over the spot area; 
%V=V single spot/V total spot) were used for quantitative analysis in order to decrease 
experimental errors. 
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2.5.9 In situ digestion.  
Trypsin, DTT, iodoacetamide, and R-cyano-4-hydroxycinnamic acid were purchased 
from Sigma. NH4HCO3 was from Fluka. Trifluoroacetic acidhigh- performance liquid 
chromatography (HPLC) grade was from Carlo Erba. All other reagents and solvents 
were of the highest purity available from Baker. Analysis was performed on the 
Coomassie blue-stained spots excised from the gels. The spots were excised from the 
gel and destained by repetitive washes with 0.1 M NH4HCO3, pH 7.5, and acetonitrile. 
Samples were reduced by incubation with 50 ml of 10 mM DTT in 0.1 M NH4HCO3 
buffer, pH 7.5 and carboxyamidomethylated with 50 ml of 55 mM iodoacetamide in the 
same buffer. Enzymatic digestion was carried out with trypsin (12.5 ng/ml) in 10 mM 
ammonium bicarbonate buffer, pH 7.8. Gel pieces were incubated at 4°C for 2 h. 
Trypsin solution was then removed, and a new aliquot of the same solution was added; 
samples were incubatedfor 16 h at 37°C. A minimum reaction volume was used as to 
obtain the complete rehydration of the gel. Peptides were then extracted by washing the 
gel particles with 10mM ammonium bicarbonate and 1% formic acid in 50%acetonitrile 
at room temperature. The resulting peptide mixtures were filtrated using 0.22 µm PDVF 
filter from Millipore, following the recommended procedure.  
 
2.5.10 NanoHPLC-chip MS/MS analysis.  
The peptide mixtures were analysed using a CHIP MS 6520 QTOF equipped with a 
capillary 1200 HPLC system and a chip cube (Agilent Technologies, Palo Alto, Ca). 
After loading, the peptide mixture (8 ul in 0.1% formic acid) was first concentrated and 
washed at 4 ul min-1 in 40 nl enrichment column (Agilent Technologies chip), with 
0.1% formic acid in 2% acetonitrile as eluent. The sample was then fractionated on a 
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C18 reverse-phase capillary column (75 um x 43 mm in the Agilent Technologies chip) 
at flow rate of 400 nl min-1 with a linear gradient of eluent B (0.1% formic acid in 95% 
acetonitrile) in A (0.1% formic acid in 2% acetonitrile) from 7 to 60% in 50 min. 
Peptide analysis was performed using data-dependent acquisition of one MS scan (mass 
range from 400 to 2000 m/z) followed by MS/MS scans of the three most abundant ions 
in each MS scan. The acquired MS/MS spectra were transformed in Mascot generic file 
format and used for peptides identification with a licensed version of MASCOT 2.1, in 
a local database (Swiss Pro). 
 
2.5.11 Protein identification.  
Raw data from nano-LC–MS/MS were analysed using Qualitative Analysis software, 
and MSMS spectra were searched against non-redundant protein databases (NCBInr 
20090924, 9760158 sequences) and UniprotSwissprot (2011, 167910 sequences), with 
the taxonomy restriction to Homo sapiens, using in-house MASCOT 2.1 software 
(Matrix Science, Boston, USA). The Mascot search parameters were:‘trypsin’ as 
enzyme allowing up to three missed cleavages, carbamidomethyl on as fixed 
modification, oxidation of M, pyroGlu N-term Q, as variable modifications, 20 ppm 
MSMS tolerance, and 0.6 Da peptide tolerance. The score used to evaluate quality of 
matches for MSMS data was higher than 32. 
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3.1 Abstract 
Aloe arborescens Miller, belonging to the Aloe genus (Liliaceae family), is one of 
the main varieties of Aloe used worldwide. Although less characterized than the 
commonest Aloe vera, Aloe arborescens is known to be richer in beneficial 
phytotherapeutic, anticancer, and radio-protective properties. It is commonly used as 
a pharmaceutical ingredient for its effect in burn treatment and ability to increase 
skin wound healing properties. However, very few studies have addressed the 
biological effects of Aloe at molecular level. The aim of the research is to provide 
evidences for the anti-proliferative properties of Aloe arborescens crude leaf extract 
using an integrated proteomic and cellular biological approach. We analysed the 
composition of an Aloe arborescens leaf extract by GC-MS analysis. We found it 
rich in Aloe-emodin, a hydroxylanthraquinone with known antitumoral activity and 
in several compounds with anti-oxidant properties. Accordingly, we show that the 
Aloe extract has antiproliferative effects on several human transformed cell lines and 
exhibits prodifferentiative effects on both primary and immortalised human 
keratinocyte. Proteomic analysis of whole cell extracts revealed the presence of 
proteins with a strong antiproliferative and antimicrobial activity specifically induced 
in human keratinocytes by Aloe treatment supporting its application as a 
therapeutical agent. 
 
3.2 Introduction 
Plants and their extracts are appreciated for their specific aroma, nutraceutical and 
therapeutical properties, such as antimicrobial, antiproliferative, anti-inflammatory, 
immunostimulant, and antioxidative (Greathead, 2003). Aloe arborescens Miller, 
belonging to the Aloe genus (Liliaceae family), is one of the main varieties of Aloe 
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used worldwide. It is commercially grown in South America (Brazil and Uruguay), 
South Africa and some Asian countries. The concentrated active extract from Aloe 
arborescens shares some therapeutical properties with the well known and studied 
Aloe vera and is commonly used in medicinal applications to treat burn wounds and 
help accelerating the healing process of the skin. Recent studies have demonstrated 
that Aloe arborescens has immunostimulating activity in animal trials (Infascelli, 
2010) and it was found to have beneficial phytotherapeutic and anticancer properties 
(Lissoni, 2009). It is known that the anticancer properties of Aloe arborescens 
depend not only on its immuno-modulatory effect, but also on a direct inhibition of 
cancer cell proliferation (Bedini, 2009). Immunostimulatory effects are due to 
acemannan while antiproliferative effects have been ascribed to anthracenic, 
antraquinonic and aloenin-like compounds (Lissoni, 2009). Aloe arborescens is also 
known for its effective burn treatment and ability to increase skin wound healing 
properties. Furthermore, it has been shown to be useful in reducing microbial growth 
and to kill a broad range of viruses and fungi, thereby providing extraordinary 
support for the gastrointestinal tract, mucous membranes and connective tissue 
(Falcetti A., personal communications).  
To determine the therapeutic effects of Aloe arborescens, a considerable number of 
clinical investigations have been done; however, very few studies have addressed the 
biological effects of Aloe at molecular level. The aim of the present study is to 
analyze the cellular response to treatment with Aloe arborescens crude leaf extract 
through a biochemical and cellular approach in order to support its application as a 
therapeutical agent. 
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3.3 Materials and Methods 
3.3.1 Preparation of the whole-leaf extract. Plants from Italian farms (Marsala, 
Sicily) certified for organic systems were cultivated in natural habitat and were 
harvested when they were older than 4 years. The leaves were washed in tanks, laid 
in plastic bags and successively washed at 25°C and brushed in order to eliminate 
external impurity. After air-drying the leaves were submitted to a “cold method” 
provided by HDR sas (Caserta, Italy) which allows to extract the active principles 
either from the inner part or from the cuticle. Commercial preparation of Aloe extract 
was stabilized by potassium sorbate and citric acid. Successively, the extract were 
stored in stainless still containers which were sealed to avoid air contact.  
 
3.3.2 Cell culture and Aloe arborescens treatment. NHEK primary cells, derived 
from neonatal foreskin, were from Clonetics (San Diego, California).The HaCaT 
(human spontaneously immortalized keratinocyte), MDA-MB231 (human breast 
adenocarcinoma) cell lines were maintained in Dulbecco’s Modified Eagle’s 
Medium (DMEM) supplemented with 10% fetal bovine serum and 1% penicillin-
streptomycin. The keratinocyte-derived squamous carcinoma cell lines (SCC011 and 
SCC012) were previously described (Lefort et al., 2007). The A431 (human 
epidermoid carcinoma) cell line was maintained in RPMI 1640 supplemented with 
10% fetal bovine serum and 1% penicillin-streptomycin. All cell lines were cultured 
at 37°C in humidified atmosphere of 5% CO2. Aliquots of Aloe arborescens fresh 
leaf extract were centrifuged at 10000 rpm for 10 min and sterilized using disposable 
Millex syringe filter units, pore size 0.22 mm (Millipore). Sterile extract was 
employed for the treatment at 10, 20 and 50% v/v, as indicated, in cell culture 
medium. Equal amounts of Aloe preservation medium were added to control 
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samples. Aloe-treated and untreated cells were photographed and harvested for 
Western-blot analysis as described below. 
 
3.3.3 Cell growth analysis. HaCaT spontaneously immortalized human 
keratinocytes, MDA-MB231 metastatic breast adenocarcinoma, A431 human 
epidermoid carcinoma, CaCo2 human epithelial colorectal adenocarcinoma cells, 
SCC011 and SCC022 squamous cell carcinoma were plated in 35mm dishes, at the 
cell density of 1 x 105 cells/plate. Cells were cultured in complete growth media 
supplemented or not with aliquots of fresh Aloe arborescence extract (10% v/v) for 
6, 24, 30, 48 and 54 hrs, collected, and counted in a Burker chamber. Cell extracts 
from treated and untreated cells were prepared and subjected to SDS-PAGE and 
immunoblot for gene-expression analysis.  
 
3.3.4 Flow cytometry analysis. After treatments, cells were washed twice with PBS 
and harvested with 0.05% trypsin in 0.15% Na2EDTA. Cells were then centrifuged, 
washed in PBS, fixed with ice-cold 70% ethanol, and stored overnight at 4°C. Fixed 
cells were washed in PBS and then incubated with propidium iodide (50 mg/ml) and 
RNAse A (10 mg/ml) for 30 min at room temperature. Data acquisition was 
performed using a CyAn ADP Flow Cytometer (Beckman Coulter, Inc., Milano, 
Italy) and Summit Software. 
 
3.3.5 Keratinocyte differentiation. Non tumorigenic HaCaT cells were chosen 
because they retain the ability to differentiate upon Ca2+ treatment thus representing 
an intermediary between normal and cancerous keratinocytes.  HaCaT cells were 
grown to confluence in complete growth medium and switched into differentiation 
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medium (serum-free DMEM) with 1.2 mM CaCl2 with or without Aloe extract (10% 
v/v) for 6 days according to (Vivo et al., 2009), with the exception that the medium 
was changed every 48 hours. Differentiated cells treated or not with Aloe were 
photographed and harvested for SDS-PAGE and immunoblot analysis as described 
below. NHEK cells were propagated in serum-free keratinocyte growth medium 
containing 0.05 mM calcium. NHEK cells with 70%–80% cell confluency were 
switched to high-calcium medium (1.2 mM) to induce differentiation. Extracts from 
Aloe-treated or untreated NHEK cells were then subjected to SDS-PAGE and 
immunoblot analysis as described below. 
 
3.3.6 SDS-PAGE and immunoblot analysis. Aloe arborescens treated and 
untreated cells were harvested in lysis buffer (50 mM Tris-HCl pH 7.5, 5 mM 
EDTA, 150 mM NaCl, 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, 0.5% 
sodium deoxycholate, and protease inhibitors). Cell lysates were incubated on ice for 
40 minutes, and the extracts were centrifuged at 13200 rpm for 15 minutes to remove 
cell debris. Protein concentrations were determined by the Bio-Rad protein assay 
(Bio-Rad). After the addition of 2x Laemmli buffer (SIGMA), the samples were 
boiled at 100°C for 5 minutes and resolved by SDS-polyacrylamide gel 
electrophoresis. Proteins were transferred to a polyvinylidene difluoride membrane 
(Millipore). The PVDF membrane was blocked in 5% w/v milk buffer (5% w/v non-
fat dried milk, 50 mM Tris, 200 mM NaCl, 0,2% Tween 20) and incubated with 
primary antibodies diluted in 5% w/v milk or bovine serum albumine buffer for 2 
hours at room temperature or overnight at 4°C. Primary antibodies were anti-mouse 
p63-4A4 (Calbiochem), anti-mouse involucrin (Abcam antibody), anti-mouse 
cytokeratin 1 (Santa-Cruz biotechnology), anti-rabbit transglutaminase type 2 
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(Abcam antibody), anti-rabbit pErks 42/44 (Cell signalling), anti-rabbit p21 (Santa-
Cruz biotechnology), anti-rabbit cyclin D1 (Cell Signalling), anti-rabbit PARP-1 
(Cell Signalling), anti-goat β-actin (Santa-Cruz biotechnology). Data were visualized 
by enhanced chemiluminescence method (ECL, GE-Healthcare) using HRP-
conjugated secondary antibodies (Santa-Cruz biotechnology) incubated for 1 hour at 
room temeperature, and analysed by Quantity One ®software of ChemiDoc TMXRS 
system (Bio-Rad). 
 
3.3.7 Cell fluorescent staining. SCC011 and SCC022 cells were seeded on sterile 
coverslips, and treated or not with Aloe arborescens extract (10% v/v) for 48hrs. 
After the treatment three washes with PBS were performed and cells were fixed with 
4% paraformaldehyde at RT for 15 minutes. Then, cells were incubated with WGA 
(Wheat Germ Agglutinin) membrane fluorescent stain (1:200) for 1h at 37°C. After 
three washes with PBS cells were permeabilized with 0.5% Triton-X100 (Sigma-
Aldrich, Selze/Germany) at room temperature for 5 minutes. Following 
permeabilization cells were incubated with DAPI (1:10000) for 3 minutes at RT. 
After three washes with 0.05% PBS-Tween, slides were mounted and analyzed. 
 
3.3.8 Metabolite analysis. Aliquots of commercial preparation of aloe extract were 
submitted to liquid-liquid extraction procedure by using equal amount of chloroform 
(1:1 v/v). The extraction step was performed three times and the organic extracts 
were collected and dried. Analyte mixtures were finally trimethylsilylated in 200 µl 
of N, O-bis(trimethylsilyl) acetamide (TMSA) at 80°C for 45 min. The sample was 
dried down under nitrogen, dissolved in 50 µl of hexane and centrifuged to remove 
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the excess of solid reagents. The hexane supernatant (1/50) was used for the GC-MS 
analysis.  
 
3.3.9 GCMS analysis. GC-MS analyses were performed on a 5390 MSD quadrupole 
mass spectrometer (Agilent technologies) equipped with a gas chromatograph by 
using a DB-5MS fused silica capillary column (30 m, 0.5 mm ID, 0.25 µm ft) from 
G&W. The injection temperature was 250°C. For lipid analyses the oven temperature 
was increased from 25°C to 90°C in 1 min and held at 90°C for 1 min before 
increasing to 140°C at 25°C/min, to 200°C at 5°C/min and finally to 300°C at 
10°C/min.. Electron Ionisation (EI) mass spectra were recorded by continuous 
quadrupole scanning at 70eV ionisation energy. Each species was interpreted on the 
basis of electron impact spectra (NIST library and Analyst Software). 
 
3.3.10 Two dimensional electrophoresis (2DE). The first dimensional 
electrophoresis (isoelectric focusing, IEF) was carried out on non-linear wide-range 
immobilized pH gradients (pH 4-7; 7 cm long IPG strips; GE Healthcare, Uppsala, 
Sweden) and achieved using the Ettan IPGphor system (GE Healthcare, Uppsala, 
Sweden). 200 mg of protein extracts were precipitated with methanol/chloroform 
according to (Wessel et al., 1984) and solubilized in 125 µl of rehydratation buffer 
and 0,2% (v/v) carrier ampholyte for 12h, at 50 mA, at 20° C. The strips were then 
focused according to the following electrical conditions at 20°C: 500 V for 30 min, 
1000 V for 30 min, 5000 V for 10h, until a total of 15000 Vt was reached. After 
focusing, analytical and preparative IPG strips were equilibrated for 15 min in 6 M 
urea, 30% (V/V) glycerol, 2% (w/V) SDS, 0.05 M Tris-HCl, pH 6.8, 1% (w/V) DTT, 
and subsequently for 15 min in the same urea/SDS/Tris buffer solution but 
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substituting the 1% (w/V) DTT with 2.5% (w/V) iodoacetamide. The second 
dimension was carried out on 12.5% (w/w) polyacrylamide gels (10 cm x 8 cm x 
0.75 mm) at 25 mA/gel constant current and 10°C until the dye front reached the 
bottom of the gel, according to (Laemmli  et al., 1970; Hochstrasser et al., 1988). 
MS-preparative gels were stained overnight with colloidal Coomassie Brilliant Blue 
and destained with MilliQ grade water. 
 
3.3.11 Image analysis. Gels images were acquired with an Epson expression 1680 
PRO scanner. Computer-aided 2-D image analysis was carried out using the 
ImageMasterTM 2D Platinum software. Relative spot volumes (%V) (V=integration 
of OD over the spot area; %V = V single spot/V total spot) were used for quantitative 
analysis in order to decrease experimental errors.  
 
3.3.12 In situ digestion. Trypsin, dithiothreitol (DTT), iodoacetamide and R-cyano-
4-hydroxycinnamic acid were purchased from Sigma. NH4HCO3 was from Fluka. 
Trifluoroacetic acid (TFA)-HPLC grade was from Carlo Erba. All other reagents and 
solvents were of the highest purity available from Baker. Analysis was performed on 
the Coomassie blue-stained spots excised from the gels. The spots were excised from 
the gel and destained  by repetitive washes with 0.1 M NH4HCO3, pH 7.5, and 
acetonitrile. Samples were reduced by incubation with 50 µL of 10 mM DTT in 0.1 
M NH4HCO3 buffer, pH 7.5 and carboxyamidomethylated with 50 µL of 55 mM 
iodoacetamide in the same buffer. Enzymatic digestion was carried out with trypsin 
(12.5 ng/µL) in 10 mM ammonium bicarbonate buffer, pH 7.8. Gel pieces were 
incubated at 4 °C for 2 h. Trypsin solution was then removed and a new aliquot of 
the same solution was added; samples were incubated for 16 h at 37 °C. A minimum 
   CHAPTER 3 
! 75!
reaction volume was used as to obtain the complete rehydratation of the gel. Peptides 
were then extracted by washing the gel particles with 10 mM ammonium bicarbonate 
and 1% formic acid in 50% acetonitrile at room temperature. The resulting peptide 
mixtures were filtrated using 0.22 um PDVF filter from Millipore, following the 
recommended procedure.  
 
3.3.13 NanoHPLC-chip MS/MS Analysis. The peptide mixtures were analysed using 
a CHIP MS 6520 QTOF equipped with a capillary 1200 HPLC system and a chip cube 
(Agilent Technologies, Palo Alto, Ca). After loading, the peptide mixture (8 µL in 0.1 
% formic acid) was first concentrated and washed at 4 µL min-1 in 40 nl enrichment 
column (Agilent Technologies chip), with 0.1 % formic acid in 2 % acetonitrile as 
eluent. The sample was then fractionated on a C18 reverse-phase capillary column (75 
µm x 43 mm in the Agilent Technologies chip) at flow rate of 400 nl min-1 with a linear 
gradient of eluent B (0.1% formic acid in 95% acetonitrile) in A (0.1% formic acid in 
2% acetonitrile) from 7 to 60 % in 50 min. 
Peptide analysis was performed using data-dependent acquisition of one MS scan (mass 
range from 400 to 2000 m/z) followed by MS/MS scans of the three most abundant ions 
in each MS scan. The acquired MS/MS spectra were transformed in Mascot generic file 
format and used for peptides identification with a licensed version of MASCOT 2.1, in 
a local database (Swiss Pro). 
 
3.3.14 Protein Identification. Raw data from nano-LC–MS/MS were analyzed using 
Qualitative Analysis software and MSMS spectra were searched against non-redundant 
protein databases (NCBInr 20090924, 9760158 sequences) and UniprotSwissprot 
(2011, 167910 sequences), with the taxonomy restriction to Homo sapiens, using in 
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house MASCOT 2.1 software (Matrix Science, Boston, USA). 
The Mascot search parameters were: “trypsin” as enzyme allowing up to 3 missed 
cleavages, carbamidomethyl on as fixed modification, oxidation of M, pyroGlu N-term 
Q, as variable modifications, 20 ppm MSMS tolerance and 0.6 Da peptide tolerance. 
The score used to evaluate quality of matches for MSMS data was higher than 32. 
 
3.3.15 Phase-contrast microscopy. HaCaT and A431 cells were grown and 
(HaCaT) induced to differentiate on glass coverslips in 6-well plates, washed with 
phosphate-buffered saline (PBS) and fixed with cold methanol for 10 minutes. 
Treated and not-treated cells were photographed (40x) with Olympus BX51 
microscope. 
 
3.3.16 Bacterial strains and growth conditions. Bacterial strains used in this study 
were Bacillus cereus (6A2) (Naclerio et al., 1993), Staphylococcus aureus (ATCC 
6538), Listeria monocitogenes (ATCC 7644), Salmonella typhimurium  (ATCC 
14028), Shigella sonnei (ATCC25931), Escherichia coli (DH5α), Bacillus subtilis 
(PY79) (Youngman et al., 1984) , Lactobacillus mucosae (SF1031) and 
Lactobacillus gasseri (SF1109) (Fakhry et al., 2009). Lactobacilli cultures were 
cultured in MRS broth (Difco) at 37°C in microaerophilic conditions, while for all 
other strains, LB medium (8 g/l NaCl, 10 g/l tryptone, 5 g/l yeast extract) and aerobic 
conditions at 37°C were used. Aloe-containing liquid media, obtained by adding 2 ml 
of an aqueous Aloe leaf extract to 8 ml of LB or MRS media, were inoculated with 
0.1 ml of an overnight culture and growth at 37°C followed for 8-12 hours by 
spectrophotometer (OD600) analysis.  
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3.3.17 Plate antibacterial assays. For each indicator strain utilized, 100 µl aliquots 
of exponential growth cultures were mixed with 10 ml of LB or MRS soft agar 
(0.7%). Plates were then spotted with 10µl of Aloe arborescens extract, incubated at 
37°C and the inhibition halo measured as previously reported (Baccigalupi et al., 
2005). The effects of Aloe arborescens extracts on bacterial growth were also 
measured on LB and MRS agar plates prepared by adding various dilutions of Aloe 
extract (1:1, 1:5, 1:10) to the media and then spotting on the solidified plates aliquots 
(10 µl) of each bacterial culture in stationary growth phase. Aloe-containing plates 
were then incubated 37°C and checked for bacterial growth after 24 and 48 hours. 
 
3.4 Results and Discussion 
3.4.1 GC-MS analysis 
The composition of the Aloe arborescens preparation was determined by GC-MS 
analyses following liquid-liquid extraction of different analytes from the extract. The 
extracted mixture of species was derivatised to TMS-derivatives and directly 
analysed by GC-MS by monitoring the total ion current as a function of time. Each 
species was univocally identified on the basis of the electron impact fragmentation 
spectra. All the analyses were performed as triplicates. The chromatograms of 
organic phase extracted in chloroform essentially revealed the presence of hesenoic 
(C6H12O2), sorbic (C6H8O2), and benzoic acid (C6H8O7). In the aqueous phase 22 
predominant species were identified and are listed in TABLE 1. Aloin, one of the main 
component of Aloe species with known pharmacological activities, was not detected 
while a significant amount of Aloe-emodin, a hydroxylanthraquinone having specific 
antineuroectodermal tumor activity (Pecere, 2000), was present (14%). 
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TABLE 1. List of species identified by GC-MS in the Aloe arborescens commercial 
preparation. The relative abundance is expressed as percentage of total volume 
injected. Preservatives are indicated in bold. 
 
3.4.2 Aloe arborescens affects cancer cell proliferation 
It is already known that Aloe arborescens has anti-proliferative and anti cancer effects 
(Lissoni, 2009; Bedini, 2009), however the molecular mechanisms underlying the 
cellular response to Aloe treatment remains to be defined. This prompted us to analyze 
the effect of an Aloe arborescens leaf extract on cell proliferation at cellular and 
molecular level, by comparing the rate of cell proliferation, the cell-cycle distribution 
and the expression of cell cycle-related molecular markers in Aloe-treated and untreated 
human cells. These analyses were performed in A431 (epidermoid skin carcinoma), 
MDA-MB231 (metastatic breast cancer), CaCo-2 (epithelial colorectal 
adenocarcinoma) and HaCaT spontaneously immortalized keratinocytes. As shown in 
Figure 1, we reproducibly found that Aloe extract reduces the cell proliferation rate in 
all cell lines tested. At 54 hrs of exposure to Aloe, a 30 to 40% reduction in the number 
of cells was observed in MDA-MB231, CaCo2 and HaCaT cells while A431 cells, 
stopped to proliferate and underwent massive cell death (Figure 1D). 
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Figure 1. (A) Proliferating HaCaT, (B) MDA-MB231, (C) CaCo-2, (D) A431 cells were 
incubated in complete cell culture medium supplemented or not with Aloe extract (1:10 
v/v). Control and Aloe-treated cells were collected at 6, 24, 30, 48 and 54 hours and 
counted in a Burker chamber. (E) Proliferating CaCo-2, (F) MDA-231, (G) A431 cells 
were incubated in complete cell culture medium supplemented or not Aloe extract (1:10 
v/v). Control and Aloe-treated cells were harvested at indicated different times (hrs). 
Equal amount of cell lysates were subjected to immunoblot analysis with antibodies 
against cyclin D1 and p21WAF. Actin was used as a loading control. 
 
The cell cycle distribution of control and Aloe-treated cells by flow cytometry show that 
HaCaT cells display only a slight increase (3%) in the percentage of G2/M cells after 48 
hrs of Aloe treatment (Figure 2), while the other cell lines tested display an increase of 
cells in S and/or G2/M phase with a compensatory decrease of G0/G1 phase population 
indicating that cells were unable to resume the cell cycle at normal phase transit rate. 
Moreover, except for HaCaT keratinocytes, Aloe treatment also caused a significant 
increase in sub-G1 cell population.  
A B 
C D 
to     6     24    30    48   54 
Caco-2 
- + - + - + - + - + - 
p21WAF 
cyclin D1 
actin 
 To        6           24         30          48        54      hrs 
E 
F 
MDA-MB231 
   -      -      +      -      +      -     + 
 To           6            24          48 
p21WAF 
cyclin D1 
actin 
hrs 
Aloe 
A 431 
p21WAF 
cyclin D1 
actin 
   -      -      +       -      +      -     + 
 To         6              24            48 hrs 
Aloe 
Aloe 
G 
   CHAPTER 3 
! 80!
Expression of the cell cycle markers p21WAF and Cyclin D1 was also investigated to 
explore Aloe effect at the molecular level. Immunoblots with the appropriate antibodies 
show that Aloe treatment significantly induced p21WAF in all tumor cells tested while 
Cyclin D1 expression was inhibited in CaCo-2 and MDA-MB231 cells (Figure 1E and 
F). Cyclin D1 is a labile factor required at high level for progression through the G1 
phase of the cell cycle. Mitogenic pathways directly up-regulate the expression of 
Cyclin D1, therefore, impaired induction of Cyclin D1 with the concomitant increase of 
p21WAF is perfectly in line with the ineffectiveness of Aloe-treated cells to efficiently 
resume the cell cycle.  Unexpectedly, A431 cells seemed to be unable to regulate Cyclin 
D1 expression (Figure 1G). We can speculate that the delay or failure of Cyclin D1 
induction with the concomitant increase of p21WAF might be responsible, at least in 
part, for the massive A431 cell detachment at 54 hrs of Aloe treatment.  Importantly, 
although we observed an increase of sub-G1 cells upon Aloe treatment (Figure 2), we 
were unable to observe PARP-1 cleavage by western blot analyses (data not shown) 
thereby indicating that Aloe treatment was not inducing apoptosis.  
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Figure 2. Representative data obtained from flow-cytometric analysis of cell cycle of 
HaCat, MDA-MB231, CaCo-2 and A-431cells incubated with or without Aloe for 48 
hours.  
 
3.4.3 Aloe arborescens induces keratinocyte differentiation 
The concentrated leaf extract from Aloe arborescens plants has been used for hundreds 
of years in medicinal applications to help accelerating the healing process of the skin. 
Therefore, we decided to analyze the effect of Aloe arborescens on differentiation of 
human keratinocytes. We decided to compare the behavior of HaCaT cells 
(spontaneously immortalized human keratinocytes) that retain the ability to differentiate 
upon Ca2+ treatment with that of human primary keratinocytes. Addition of calcium to 
keratinocyte cultures is the most physiological stimulus to elicit a rather complete 
differentiation program, inducing not only biochemical markers but also many of the 
structural changes occurring in vivo (Dotto, 1999). To check whether the differentiation 
profile is altered by Aloe treatment, HaCaT cells were induced to terminally 
differentiate by adding 1.2 mM calcium in a serum-free medium, supplemented or not 
with Aloe extract. After 6 days of culture, Aloe treated cells became shrunked and 
pluristratified (Figure 3A). To provide molecular evidence that differentiation was 
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anticipated by Aloe-treatment, we performed immunoblot analyses on extracts derived 
from treated and untreated cells. In particular, we observed that Involucrin and 
Transglutaminase, two well characterized differentiation markers (Paramio, 1997) were 
expressed at higher levels in Aloe-treated cells.  Conversely, DNp63a that is associated 
with the proliferative potential of epithelial cells and disappears in terminally 
differentiated keratinocytes (Di Costanzo, 2009), was down-regulated earlier upon Aloe 
treatment (Figure 3B).  
In human primary keratinocytes (NHEK), Aloe treatment caused a dramatic increase of 
Involucrin gene expression that was already evident after 1 day of treatment. Similarly 
to what we have observed in HaCaT cells, DNp63a level decreased faster in Aloe-
treated keratinocytes compared with control cells (Figure 3C).  
We then looked more deeply into the effect of Aloe treatment during the early phases of 
HaCaT cell differentiation. To this purpose, HaCaT cells were seeded at medium 
density (2.5x105) in complete medium supplemented or not with Aloe extract (1:10 v/v) 
and collected before Aloe addition (t0) or after 6, 24, 30, 48 and 54 hours after Aloe 
treatment (Figure 3D). Equal amounts of cell lysates were subjected to immunoblot 
analysis to detect endogenous p21WAF and Cyclin D1. DNp63a and Cytokeratin 1 
(CK1) were also monitored as early differentiation markers. As shown in Figure 3D, we 
initially observed an increase of Cyclin D1 protein levels both in Aloe-treated and 
untreated keratinocytes. However, according to what observed in tumor cells, Cyclin D1 
tended to be down-regulated faster in Aloe-treated HaCaT cells while the p21WAF 
protein was up-regulated only in Aloe-treated cells. At 54 hrs of Aloe treatment, the 
remarkable decrease of Cyclin D1 along with sustained expression of p21WAF indicate 
that keratinocytes were anticipating cell cycle withdrawal. p21WAF-depleted 
keratinocytes exhibit an increased proliferative potential and a drastic down-modulation 
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of keratinocyte differentiation markers (Di Cunto, 1998) pointing to an essential 
involvement of p21WAF in the control of keratinocyte terminal differentiation. In line 
with these observations, compared to control cells, Aloe-treated keratinocytes exhibited 
higher levels of p21WAF and CK1, in agreement with the induction of a differentiation 
program. However, the persistence of DNp63a protein expression indicates that both 
treated and untreated keratinocytes were not fully differentiated (Figure 3D).  
Cyclin D1 protein is known to increase under mitogenic signals, through activation of 
the ERK’s pathway. Remarkably, immunoblot analysis of lysates from proliferating 
HaCaT keratinocytes treated for 24 hrs with increasing amounts of Aloe arborescens 
extract (20% or 50% v/v) show that the reduction of Cyclin D1 and phosphorylated 
ERKs, as well as the induction of p21WAF and CK1, was dose-dependent. Moreover, 
the signal corresponding to the cleavage of PARP1 was not enhanced, thus indicating 
that cells were not undergoing apoptosis (Figure 3E). We then decided to look at the 
effect of Aloe treatment on squamous carcinoma cell lines (SCC011 and SCC022). 
Squamous cell carcinoma (SCC) is an uncontrolled growth of abnormal cells arising in 
the squamous layer, which composes most of the skin’s upper layers. SCC cells retain 
high levels of DNp63a that is absolutely required for the survival of early stages of the 
squamous carcinoma. We first determined the rate of cell proliferation in control and 
Aloe-treated SCC011 and SCC022 cells. As shown in Figure 4A and B, in Aloe 
containing medium both SCC011 and SCC022 cells stop growing. The cell cycle profile 
of Aloe-treated SCC022 cells reveals a dramatic increase in percentage of sub-G1 cells 
at the expenses of G1 and G2/M cells (Figure 4C). 
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Figure 3. (A) Confluent HaCaT cells were induced to terminally differentiate by serum 
withdrawal and calcium addition (1,2 mM) in DMEM cell culture media supplemented 
or not with Aloe extract (1:10 v/v). After 6 days of culture treated and not-treated cells 
were fixed with cold methanol and analyzed by phase-contrast microscopy. (B) 
Differentiated HaCaT and (C) NHEK cells in presence or absence of Aloe extract (1:10 
v/v) were collected at different indicated times. Equal amount of cell lysates were 
subjected to immunoblot analysis with antibodies against DNp63a, involucrin and 
transglutaminase type II. Actin was used as a loading control. (D) Proliferating HaCaT 
cells were incubated in DMEM or DMEM Aloe extract containing medium (1:10 v/v). 
Control and Aloe-treated cells were collected at 6, 24, 30, 48 and 54 hours. Equal 
amount of cell lysates were subjected to immunoblot analysis with antibodies against 
DNp63a, cyclin D1, p21WAF and Keratin 1, an early differentiation marker. Actin was 
used as a loading control. (E) Proliferating HaCaT cells were incubated in DMEM or 
DMEM Aloe extract containing medium (20% or 50% v/v). Control and Aloe-treated 
cells were collected at 24 hours. Equal amount of cell lysates were subjected to 
immunoblot analysis with antibodies against cyclin D1, p21WAF, Keratin 1 an early 
differentiation marker and PARP-1. Actin was used as a loading control. 
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In SCC011 the increase of subG1 cells was less dramatic although the S phase arrest 
was evident (Figure 4D). Growth arrest was associated with a characteristic enlarged 
and flattened cell morphology as shown by fluorescence microscopy in SCC011 cells 
(Figure 4E). Interestingly, compared to SCC022, SCC011 cells display a stronger 
activation of the Akt survival marker (data not shown) suggesting that Akt may, indeed, 
counteract Aloe-induced cell death. Western blot analysis of control and Aloe treated 
SCC011 shows a dramatic decrease of DNp63a and a concomitant increase of p21WAF 
and CK1 polymers (Figure 4F). Importantly, since it has been shown that SCC011 and 
SCC022 proliferation is strictly dependent on DNp63a (Rocco, 2006), the dramatic 
reduction of DNp63a induced by Aloe in these tumor cells may account for the cell 
death observed. 
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Figure 4. (A) Proliferating SCC022 and (B) SCC011 cells were incubated in complete 
cell culture medium supplemented or not with Aloe extract (1:10 v/v). Control and Aloe-
treated cells were collected at 6, 24, 30, 48 and 54 hours and counted in a Burker 
chamber. (C) and (D) Representative data obtained from flow-cytometric analysis of 
cell cycle of SCC022 and SCC011 cells incubated with or without Aloe for 48 hours. (E) 
Representative images of SCC011 cells fluorescently stained with WGA (labeling 
membrane glycoproteins) or DAPI (F) Equal amount of cell lysates were subjected to 
immunoblot analysis with indicated antibodies. Actin was used as a loading control. 
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3.4.4 Antibacterial tests 
Inner-leaf extract from Aloe vera was shown to inhibit growth of Streptococcus and 
Shigella species in vitro (Arunkumar, 2009). Aloe-emodin, has been proposed to have 
direct antimicrobial activity. To assess whether the Aloe aqueous extract had 
antibacterial effects, two different plate antibacterial assays were performed with a 
panel of nine bacterial strains. As a first assay, LB or MRS plates were disseminated 
with each of the bacterial strain and spotted with the aliquots of Aloe extract. As a 
second assay, LB or MRS solid media containing various amounts of Aloe extract were 
spotted with aliquots of bacterial cells previously grown in liquid media. With both 
assays no inhibition of bacterial growth was observed for any of the nine bacterial 
strains analyzed (data not shown).  
 
3.4.5 Proteomic analysis 
Although Aloe arborescens extract has been largely used for its immunostimulating and 
anticancer properties, little is known of its impact at the proteome level. We thus 
decided to look at cell proteome changes of HaCaT keratinocytes induced by Aloe 
treatment. Protein extracts from untreated (Control) or Aloe treated (Sample) HaCaT 
cells were fractionated by 2D-GE and stained with colloidal Blue Coomassie. The gels 
were run in triplicate and compared using the ImageMaster 2D Platinum 6.0 software. 
A few initial reference points (landmarks) were affixed for gels alignment in the first 
step of the images analysis. The spots were detected on the gels and the software 
“matched” the gels and the corresponding spots. The spots representing the same 
protein in different gels were paired. Pairs were automatically determined using 
ImageMaster powerful gel matching algorithm. The different 2DE images were 
compared by synchronized 3-D spots view. Among the spots corresponding to Aloe 
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sensitive proteins clearly detected in repeated trials, 17 were selected for proteomic 
analysis. The image analysis enabled the identification of 8 spots that were present 
either in higher amount or exclusively in the Aloe-treated sample, thereby indicating 
that they were induced by Aloe treatment. In the control sample, instead, 9 spots that 
were undetectable or whose signal decreased after Aloe treatment were detected. These 
spots were selected for mass spectral identification by the merging of images analyses. 
Proteins excised from the gel were reduced, alkylated and, in situ, digested with trypsin. 
The resulting peptide mixtures were analyzed by nanoLC/MS/MS experiments. The 
peptide mixtures were fractionated by nanoHPLC and sequenced by tandem mass 
spectrometry, generating sequence information on individual peptides. MSMS spectra 
were used to search for a non-redundant sequence using the in-house MASCOT 
software, thus taking advantage of the specificity of trypsin and of the taxonomic 
category of the samples. The number of measured masses that matched within the given 
mass accuracy was recorded and the proteins that had the highest number of peptide 
matches were examined leading to the identification of the protein components. As 
further selection criteria, only the proteins, identified by MASCOT search with at least 
2 peptides, and found exclusively in the replicates were selected. The list of proteins 
identified by this approach is illustrated in Table 2. 
Among the identified proteins, a signal corresponding to Tubulin showed an increment 
in the treated sample as well as that of a powerful antimicrobial peptide known as 
Dermcidin. This observation was particularly intriguing as we failed to detect a direct 
antimicrobial activity of Aloe arborescens against several bacterial strains (see above). 
Dermcidin (DCD) is constitutively expressed in eccrine sweat glands and is part of the 
constitutive innate defence of human skin and stimulates keratinocytes to produce 
cytokines and chemokines (Niyonsaba, 2009). So far, no Dermcidin expression was 
   CHAPTER 3 
! 89!
found, neither at RNA nor at protein level, in primary keratinocytes, fibroblasts and 
melanocytes both in normal conditions, or in cells stimulated by LPS, TNFα or TPA. 
Although the Aloe ability to stimulate Dermcidin production by keratinocytes needs 
further investigations, our observation provides a novel insight for the Aloe implication 
in microbicidal ability and skin immunity. Aloe treatment also induced the expression of 
molecules involved in several aspects of keratinocyte proliferation and differentiation 
such as GRP78, Prohibitin and Stathmin. Prohibitin is a potential tumor suppressor 
protein that exhibits growth suppressor ability by repressing E2F-mediated gene 
transcription (Joshi, 2003). Stathmin is a microtubule-destabilizing protein and, in 
association with Tubulin and HSP70, was reported to be functionally relevant in the 
control of numerous regulatory pathways that require a reorganization of the entire 
cytoskeleton. GRP78 (also known as HSRPA5) was found to be increased in the 
suprabasal layers of normal epidermis and can work as a molecular chaperone in 
cooperation with other Heat Shock Proteins being part of the unfolded protein response 
(UPR) activated in differentiating epidermal keratinocytes (Sugiura, 2009). In Aloe-
treated HaCaT cells, heat shock proteins, essential for the survival of malignant cells, 
were under-represented. However, heat-shock proteins also occur under non-stressful 
conditions, simply "monitoring" the cell’s recycling or folding. Further experiments are 
needed to clarify this phenomenon. 
Remarkably, Calmodulin and Keratin 1 signals were detected only in the control sample 
and disappeared following the Aloe treatment. The remaining proteins exhibited a 
sensitive decrement in the Aloe-treated sample. 
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Table 2. List of proteins differentially represented in Aloe-treated or control HaCaT 
cells identified by Mass Spectrometry.  
 
3.5 Conclusions 
The results presented in this study indicate a clear antiproliferative effect of an Aloe 
extract on several tumor cells and a prodifferentiative effect both on primary and 
immortalized human keratynocytes. 
For a medicinal application perspective, our study supports the use of Aloe arborescens 
extract for topic treatment of hyperproliferative skin diseases or skin squamous cell 
carcinoma. In vivo animal experimentation will be necessary to further confirm the 
proposed health benefit of the extract.  
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Fig. 1. A431 cell response after Aloe- extract treatment. (A) Cell death was evaluated 
after treating A431 cells with 10% v/v Aloe-extract for 54hrs, and staining with 
Annexin-V. Flow cytometry profile represents Annexin-V-FITC staining in x axis and PI 
in y axis. Numbers represent the percentage of living or dead cells (B) Apoptosis (after 
48 and 54 hrs of treatment) was assessed by Immuno-blotting of cellular total extract 
with anti-PARP1 antibody. (C) Cell proliferation was evaluated after treating A431 
cells with 10% v/v Aloe-extract for 48hrs, and staining with BrdU reagent. Flow 
cytometry profile represents DNA content- PI staining in x axis and BrdU incorporation 
in y axis. The number represents the percentage of cell distribution during the cell 
cycle. 
 
 
8.1 Materials and Methods 
 
Annexin V staining. After Aloe extract treatment (10% v/v for 54hrs), cells were 
washed twice with PBS and harvested with 0.05% trypsin in 0.15% Na2EDTA. Cells 
were centrifuged and washed twice in PBS. Then the cell pellet were resuspended in 
Annexin V-FLUOS (Roche) labelling solution (10mM Hepes/NaOH pH 7.4, 140 mM 
NaCl, 5mM CaCl2, Annexin V labelling reagent and 1ug/ml PI reagent) and incubated 
for 10 minutes at RT. Data acquisition was performed using a CyAn ADP Flow 
Cytometer (BeckmanCoulter, Inc., Milano, Italy) and Summit Software. 
 
BrdU staining. After Aloe extract treatment (10% v/v for 48hrs) or not, cells were 
incubated with 30uM BrdU reagent (BectonDickinson kit) for 30 minutes at 37°C. Then 
cells were washed twice with PBS and harvested with 0.05% trypsin in 0.15% 
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Na2EDTA. Cells were centrifuged, washed in PBS, fixed with ice-cold 70% ethanol, 
and stored overnight at 4°C. Then fixed cells were washed in PBS and incubated with 
HCl 4M for 30 minutes at room temperature. Then cells were washed twice with PBS-
Tween 0,1% and centrifuged at 1200 rpm for 5min 4°C. The cell pellet were 
resuspended in anti- BrdU-FITC labeling solution and incubated for 1hr at RT. After 
incubation, cells were washed twice with PBS-Tween 0,1% and centrifuged at 1200 
rpm for 5min 4°C. The cell pellet were incubated with propidium iodide (50 µg/ml) and 
RNAse A (5 µg/ml) for 20 min at room temperature. Data acquisition was performed 
using a CyAn ADP Flow Cytometer (BeckmanCoulter, Inc., Milano, Italy) and Summit 
Software. 
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4.1 Abstract 
Background & Aims. A fructose-rich diet is one of the factors inducing the metabolic 
syndrome, a combination of health disorders significantly increasing the risk of diabetes 
and cardiovascular disease. The diet is also known to alter the microbial composition of 
the gut, although it is not clear whether such alteration is a consequence or one of the 
causes of the diet-induced health disorders. Aim of this work is to assess whether the 
gut microbiota is linked to the development of the diet-induced metabolic syndrome in 
rats. 
Methods. Rats were either fed a standard or high-fructose diet. Groups of fructose-fed 
rats were treated with either antibiotics or faecal samples from control rats. Body 
composition, plasma metabolic parameters and tissue oxidative stress were measured in 
all the groups. A metagenomic approach was used to evaluate the bacterial composition 
of the gut of animals under different diets.  
Results. The fructose-rich diet strongly altered the microbial composition of the gut and 
induced markers of metabolic syndrome, inflammation and oxidative stress. Metabolic 
markers of fructose-fed animals were significantly reduced when the animals were 
treated with antibiotic or fed faecal samples. The faecal transplant was also able to 
restore the microbial composition of the gut.  
Conclusions. Our data suggest that in rats on a fructose-rich diet the development of the 
metabolic syndrome is directly correlated with the alteration of the gut microbial 
population/community. The data might indicat that the manipulation of the gut 
microbiota can be considered as a possible therapeutic strategy in the treatment of the 
metabolic syndrome. 
 
 
   CHAPTER 4 
! 100!
4.2 Introduction  
It is well established that diets, rich in simple carbohydrates as sucrose and fructose, can 
induce a wide range of metabolic alterations, including obesity, increased plasma 
triglyceride concentration, impaired glucose tolerance and insulin resistance1-3. 
However, the contribution of high-fructose diets to the development of obesity remains 
controversial, since some authors have not observed unequivocal evidence linking 
fructose consumption with metabolic disorders2. To address this issue, studies with 
animal models have proven particularly informative4. A recent study performed with 
nonhuman primates has shown that even in the absence of weight gain, fructose rapidly 
causes liver damages and that hepatic steatosis relates to the duration of fructose 
consumption5. In a different study with a rat model of obesity6,7, a fructose-rich diet has 
been shown to impair glucose tolerance, to induce an oxidative stress status and to 
increase plasma non-esterified-fatty-acids (NEFA), considered as a reliable marker of 
the development of insulin resistance8.  
In the last decade the rapid development of metagenomic approaches has allowed the 
analysis of microbial communities present for example in the human gut. It is now clear 
that the microbial community found in the human gut is complex. It not only expands 
the metabolic properties of the gastrointestinal tract it also contributing to the health 
status of the host9. The role of microbes is now viewed as essential for human health 
and the gut microbiota as an important metabolic organ9. It is also clear now that the 
composition of the gut microbiota is influenced by changes of environmental factors, 
including the diet, although little is known about how individual species respond to such 
changes9. It has been reported that the presence of specific nutrient substrates can have 
an influence on the composition of the microbial community leading to changes in the 
function of the microbiota10-12. 
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In this context it is reasonable to assume that a fructose-rich diet could alter the 
composition of the gut microbiota. However, whether such alteration really occurs and 
whether it is related to the adverse effects of a fructose-rich diet on health still remains 
to be addressed. Only very recent studies have started to address the role of microbiotia 
in animal models or humans exposed to a fructose-rich diet3. Hsieh et al13 reported that 
the oral administration of a probiotic strain of Lactobacillus reuteri improves insulin 
resistance and reduces hepatic steatosis in rats fed with a fructose-rich diet, suggesting 
the probiotic-based approach as a promising therapeutic strategy in the treatment of the 
metabolic syndrome and of the type 2 diabetes. 
Here we show that the detrimental effects caused by fructose-induced obesity in adult 
rats were abolished by an antibiotic treatment, suggesting a direct involvement of the 
microbiota in the induction of the metabolic syndrome. Similar, although less marked, 
beneficial effects were observed when fructose-fed rats were inoculated with faecal 
samples of rats under standard diet. A metagenomic analysis of the gut microbiota of 
the various animals was used to evaluate the alteration of the macrobiotic gut 
community composition in animals under different diets. 
 
4.3 Materials and Methods 
4.3.1 Animals and treatments. Male Sprague-Dawley rats (Charles River, Italy), of 
100 days of age were caged singly in a temperature-controlled room (23±1°C) with a 
12-h light/dark cycle (06.30-18.30). Treatment, housing, and killing of animals met the 
guidelines set by the Italian Health Ministry. All experimental procedures involving 
animals were approved by “Comitato Etico-Scientifico per la Sperimentazione 
Animale” of the University “Federico II” of Naples.  
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Rats were divided in two groups and were fed a fructose-rich or control diet (Mucedola 
4RF21; Settimo Milanese, Milan, Italy) for 8 weeks as previously reported6, 7, 14. Rats 
fed the control diet were divided in two groups of six rats each: one group received 
water supplemented with antibiotic mix (Ampicillin 1 g/L + neomycin 0.5 g/L) (CA 
rats), while the second group did not received any further treatment and served as 
control (C rats). Rats fed the fructose-rich diet were divided in three groups, each 
composed of six rats: one group received water supplemented with the above antibiotic 
mix (FA rats), the second group was subjected to microbiota transplantation (FT rats), 
while the third group did not receive any further treatment (F rats). For microbiota 
transplantation, fresh faecal pellets (2 pellets for each rat) from all six donor rats (C rats) 
were collected and placed in transfer buffer  (pre-reduced sterile phosphate buffered 
saline containing 0.05% cysteine HCl, 2 mL/g) on ice. The faecal pellets were 
homogenized, centrifuged at 800g for 2 min and the supernatant was collected. Diluted 
faecal supernatant was then orally inoculated to recipient rats (0.5 mL/rat) every third 
day during the 8 weeks dietary treatment period. During the treatments, body weight, 
food and water intake were monitored daily. 
 
4.3.2 Metabolic analysis. To perform the glucose tolerance test the day before the 
sacrifice, rats were fasted for 6 hours from 09.00 a.m. Basal, postabsorptive blood 
sample was obtained from a small tail clip and placed in EDTA–coated tubes and then 
glucose (2 g/kg body weight) was injected intraperitoneally. Blood samples were 
collected after 20, 40, 60, 90, 120 and 150 min and placed in EDTA-coated tubes. The 
blood samples were centrifuged at 1400xgav for 8 min at 4°C. Plasma glucose 
concentration was measured by colorimetric enzymatic method (Pokler Italia, Genova, 
Italy). 
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Plasma NEFA levels were measured by colorimetric enzymatic method (Roche 
Diagnostics, Mannheim, Germany). Plasma tumor necrosis factor alpha (TNF-α) 
concentrations were determined using a rat specific enzyme linked immunosorbent assay 
(R&D Systems, MN, USA) according to manufacturer’s instruction. Plasma 
lipopolysaccharide (LPS) determinations were performed using a kit based upon a 
Limulus amaebocyte extract (LAL kit; Lonza, Basel, Switzerland).  
To evaluate body energy and lipid content, sacrificed rats were killed by decapitation 
and livers and hindleg skeletal muscles were quickly removed. Guts were cleaned of 
undigested food and the carcasses were then autoclaved. After dilution in distilled water 
and subsequent homogenisation of the carcasses, duplicate samples of the homogenised 
carcass were analyzed for energy content by bomb calorimeter7. Total body lipid content 
was measured by the Folch extraction method15. 
 
4.3.3 Isolation of epididymal adipocytes and measurement of in vitro lypolitic 
capacity. Adipocytes were isolated from intra-abdominal epididymal white adipose 
tissue (WAT) as in 14. Aliquots corresponding to 15000 cells were then incubated in the 
presence of 1 µM isoproterenol, with or without 0.1 µM insulin, for 2 h at 37 °C in a 
shaking bath. At the end of the incubation, aliquots were used for the determination of 
glycerol production, by incubating samples with Sigma glycerol reagent at 37 °C for 15 
min and then monitoring absorbance at 540 nm against appropriate standards. 
 
4.3.4 Preparation of whole tissue homogenates from liver and skeletal muscle. 
Whole tissue homogenates were prepared from liver and skeletal muscle as previously 
reported6, 16. The extent of the peroxidative processes in whole tissue homogenates was 
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determined by measuring the level of lipid hydroperoxides according to Heath & 
Tappel17. Determination of protein oxidative damage was performed measuring protein-
bound carbonyl levels by the procedure of Reznick & Packer18. 
 
4.3.5 Western blot quantification of p-Akt in skeletal muscle tissue. Skeletal muscle 
tissue samples were denatured, subjected to electrophoresis and the gels were transferred 
onto PVDF membranes (Millipore, MA, USA). After preblocking, the membranes were 
incubated overnight at 4 °C with polyclonal antibody for p-Akt (Cell Signaling, MA, 
USA, diluted 1:1000 in blocking buffer). After washing, the membranes were incubated 
1 hour at room temperature with a anti-rabbit, alkaline phosphatase-conjugated 
secondary antibody (Promega, WI, USA), and then incubated at room temperature with 
a chemiluminescent substrate, CDP-Star (Sigma-Aldrich, MO, USA). Data detection 
was carried out by exposing autoradiography films (Eastman Kodak Company, NY, 
USA) to the membranes. Quantification of signals was carried out by Un-Scan-It gel 
software (Silk Scientific, UT, USA). Akt was detected with polyclonal antibody (Cell 
Signaling, MA, USA, diluted 1:1000 in blocking buffer) and used to normalize the p-
Akt signal. 
 
4.3.6 Caecal sample preparation and DNA extraction. The caecal content was 
collected from 30 rats (six replicates for each of the five different treatment groups). 
Total genomic DNA was extracted using the QIAamp® DNA Stool Mini Kit 
(QIAGEN) following the manufacturer’s instructions. Briefly, 200mg of each sample 
were homogenized in buffer ASL and were subjected to 2 x 45s intervals of bead-
beating at speed 6.0 in a FastPrep Instrument with zirconia-silica beads (0.1-mm 
diameter, MP-Biomedicals). The tubes were incubated on ice for 2 min between bead-
   CHAPTER 4 
! 105!
beatings. After the bead-beating the samples were incubated at 95 °C for 5 min to lyse 
bacterial cells. After removal of potential inhibitors by incubation with an InhibitEx 
tablet, the lysates were treated with proteinase K and buffer AL at 70 °C for 10 min to 
remove protein and polysaccharides. DNA was precipitated by ethanol, applied to a 
column provided in the kit followed by two washing steps with buffers AW1 and AW2, 
and then dissolved in pre-heated sterile ddH2O. Genomic DNA was extracted in 
triplicate from each sample and the extracts were subsequently pooled in order to 
eliminate possible bias associated with DNA extraction.  
 
4.3.7 PCR and amplicon preparation. Primers designed by Caporaso et al.19 (515F: 
5'-GTGCCAGCMGCCGCGGTAA-3') and Andersson et al.20 (1061R: 5'-
CRRCACGAGCTGACGAC-3') were used to amplify a ≈ 540nt region of the 16S 
rRNA gene. The amplicon covers the hyper variable regions V4, V5 and V6. Each 25ul 
PCR mix contained 2X Phusion Master Mix (BioLabs® Inc., New England), 10uM of 
each PAGE-purified primer (Microsynth, Switzerland) and 2 ul of template-DNA. The 
PCR conditions used were 98°C for 30s, 15 cycles of 98°C for 10s, 52°C for 30s and 
72°C for 30s, followed by 72°C for 10min using a SensoQuest PCR cycler (Germany). 
The PCR products were checked for their length on 1,5% agarose gel with GelRed™ 
Nucleic Acid Gel Stain (Biotium Inc., USA) and purified with DNA clean and 
concentrator™-5 kit (Zymo Research, U.S.A). The DNA concentration was determined 
using Qubit® 2.0 Fluorometer and Qubit™ dsDNA HS Assays Kit (Invitrogen, Life 
Technologies). Equal amounts for each sample within the same group of the six 
replicates were pooled in order to eliminate possible bias associated with PCR 
amplification. 
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4.3.8 Illumina library preparation. Index libraries for the pooled and purified PCR 
products were prepared using the TruSeq™ DNA Sample Preparation kit following 
manufacturer’s recommended protocols (Illumina, Inc., San Diego, Ca, USA). The 
quality and the quantity of the different libraries were assessed on a Bioanalyzer 2100 
(Agilent, Palo Alto, CA) using a dsDNA HS chip (Agilent, Palo Alto, CA) and by 
qPCR using the Library Quantification Kit For Illumina sequencing platforms (KAPA 
Biosystems Inc., USA) respectively. Single read 500 cycle (SR500) sequencing was 
performed on an Illumina MiSeq at the Genomic Diversity Centre (GDC) at the ETH, 
Zurich, Switzerland following manufactures run protocols (Illumina, Inc., San Diego, 
CA, USA). The MiSeq Control Software Version 2.2 including MiSeq Reporter 2.2 was 
used for the primary analysis and the de-multiplexing of the raw reads. 
 
4.3.9 Amplicon sequencing analyses. The raw reads were quality checked and filtered. 
Cutadapt version 1.2.1 was used to remove reads with TruSeq adapter sequences38. 
Cutadapt was also used to filter and trim reads of the PCR primer start sequences. The 
filtered reads were quality checked and quality filtered using PrinSeq Lite version 
0.20.339. Reads smaller than 150 nucleotides or containing ambiguous nucleotides (e.g. 
“N”) were removed in this step. The remaining cleaned reads were de-replicated, de-
noised (identity threshold 99%) and chimera checked (de-novo and reference based 
against the 16S gold reference database provided by Qiime) using Usearch21 version 6. 
The reads were binned using reference mapping applying the Usearch option as part of 
QIIME version 1.6.040. The remaining reads were passed to the QIIME pipeline. 
Uclust21 was used to define OTUs at 97% sequence identity, which were assigned a 
taxonomy using the RDP classifier22. Representative sequences for each OTU were 
aligned with PyNast23 and columns uninformative for phylogeny building were filtered 
   CHAPTER 4 
! 107!
out using Greengenes24. The resulting alignments were used to build a phylogeny using 
FastTree25. The principal coordinates analysis (PCoA) was performed on pairwise 
unweighted UniFrac distances26. The hierarchical cluster tree was built using UPGMA 
(unweighted pair group method with arithmetic mean) on the UniFrac distance matrix.  
 
4.3.10 Statistical analysis. Data are given as means±SEM of six different rats. 
Statistical analyses were performed by one-way analysis of variance followed by Tukey 
post hoc test. Probability values less than 0.05 were considered to indicate a significant 
difference. All analyses were performed using GraphPad Prism 4 (GraphPad Software, 
San Diego, CA, USA). 
 
4.4 Results 
4.4.1 Experimental set up 
Male Sprague-Dawley rats 100 days old were used as a model of diet-induced obesity. 
Two groups of rats were fed either with control diet (group C, n=6) or with a fructose-
rich diet (group F, n=6), known to induce early signs of obesity within 8 weeks of 
treatment6, 7, 14. In order to assess the role of the gut microbiota in diet-induced obesity, 
additional groups of rats, fed the same fructose-rich diet of group F, were treated with a 
mixture of two antibiotics (group FA, n=6) or with faecal samples from rats of group C 
(group FT, n=6). To ensure that each of the FT rats received a bacterial load similar in 
number and species, stools from all six control animals were pooled and rats of group 
FT fed with aliquots of the pooled mixture A fifth, control group of rats was fed control 
diet and treated with the same antibiotics given to rats of group FA (group CA, n=6). A 
schematic summary of the experimental design is shown in Fig. 1. In all our metabolic 
analysis no differences were observed between rats of groups C and CA indicating that 
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the antibiotic treatment did not have any effect on animals under the same diet regimen. 
For this reason, results from group CA are shown, in comparison with those of group C, 
as Supplementary Material Fig. 1. 
 
 
 
Figure 1. The experimental design. Five groups of rats (n=6) were kept 8 weeks under 
different diet regimens. Group C: control diet; CA: control diet plus antibiotic 
treatment; F: low fat / high-fructose diet; FA: low fat / high-fructose  diet plus 
antibiotic treatment; FT: low fat / high-fructose diet plus faecal samples of rats of 
group C (see Methods). After 8 weeks all animals were sacrificed for analysis. 
 
4.4.2 Antibiotics or faecal samples do not affect the fructose-induced increase in 
body energy and lipid content 
A first metabolic characterization was carried out by analyzing the animal whole body 
composition. As shown in Fig. 2, fructose-fed rats displayed significantly higher body 
energy (panel A), lipids (panel B) and epididymal fat compared to controls. The 
treatment with antibiotics or faecal samples did not affect the increase in body energy 
(Fig.2A) or lipids (Fig.2B, C) due to the diet. Since changes in energy intake are the 
primary drive of obesity development, metabolisable energy (ME) intake was 
monitored throughout the experimental period to verify whether the fructose-induce 
increase in body energy and lipid content was due to an increase of ME. To this aim, 
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food intake and energy loss through faeces and urines were analyzed (Methods) and 
indicated that ME intake was similar in all experimental groups (C=19,700±1,200 kJ, 
CA=19,400±1,050 kJ, F=19,500±1,100 kJ, FA=19,200±990 kJ, FT=19,500±1,000 kJ).  
 
 
 
Figure 2. Body energy (A), lipids (B), and epididymal fat (C) content in control (C), 
fructose-fed (F), fructose-fed+antibiotic (FA) and fructose-fed+faecal samples (FT) 
rats. Values are reported as means±SEM of six different rats. * P< .05 compared to C 
rats, # P< .05 compared to F rats (one-way ANOVA followed by Tukey post-test). 
 
4.4.3 Antibiotics or faecal samples reduce markers of the fructose-induced 
metabolic syndrome  
The levels of plasma NEFA and glucose intolerance were followed as early markers of 
the development of metabolic derangement and insulin resistance. The Fig. 3A shows 
that the significant increase in plasma NEFA found in fructose-fed rats (group F vs C) 
was almost completely reversed by treatment with antibiotics (group FA) or faecal 
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samples (group FT). In addition, the inhibitory effect of insulin on lipolysis in 
epididymal WAT was nearly absent in fructose-fed rats (group F), but was completely 
restored by treatment with antibiotics (group FA) or faecal samples (group FT) (Fig. 
3B). Changes in plasma glucose after the administration of a given dose of glucose were 
plotted over the time and the area under the curves was calculated and used to estimate 
glucose tolerance. The significantly higher values observed in fructose-fed rats (group F 
vs C) indicate that, with the same glucose injection, the increase in plasma glucose 
levels was more marked in fructose-fed rats (Fig. 3C). This reduced glucose tolerance 
was abolished by antibiotic treatment (group FA), while the treatment with faecal 
samples caused only a minor, not statistically relevant, reduction (group FT) (Fig. 3C). 
To assess the contribution of skeletal muscle to changes in glucose tolerance, we 
investigated a distal effector of insulin signalling in this tissue, and we found that pAkt 
levels were significantly lower in fructose-fed (group F) and fructose-fed+faecal 
samples (group FT) rats, while this decrease was abolished by antibiotic treatment 
(group FA) (Fig. 3D, S2). 
As a third marker of the development of a metabolic syndrome, the plasma 
concentration of LPS was considered, since metabolic endotoxaemia is associated with 
obesity, metabolic syndrome and type 2 diabetes27. A statistically significant increase in 
plasma LPS levels were measured in fructose-fed rats and was partly reduced by both 
treatments, with antibiotic and faecal samples (fig. 3E). In addition, plasma 
concentrations of TNF-alpha were found four-fold higher in fructose-fed rats than in 
control animals (Fig. 3F) and both antibiotic treatment and faecal transplant were both 
able to completely abolish this increase (Fig. 3F). 
 
   CHAPTER 4 
! 111!
 
Figure 3. Plasma non esterified fatty acids (A), inhibitory effect of insulin on adipose 
tissue lipolysis (B), area under the curve of plasma glucose after glucose load (C), 
pAkt/Akt content in skeletal muscle (D), plasma LPS (E) and plasma TNF-α  (F) in 
control (C), fructose-fed (F), fructose-fed+antibiotic (FA) and fructose-fed+faecal 
samples (FT) rats. Values are reported as means±SEM of six different rats. * P< .05 
compared to C rats, # P< .05 compared to F rats (one-way ANOVA followed by Tukey 
post-test). EU=endotoxin unit. 
 
4.4.4 Antibiotics or faecal samples reduce the fructose-induced tissue oxidative 
stress. 
Oxidative damage in liver and skeletal muscle was evaluated by assessing the levels of 
damaged lipids (panels A and C of Fig. 4) and proteins (panels B and D of Fig. 4) in 
both tissues. Fructose-fed rats showed higher levels of oxidative stress than control rats 
in liver (panels A and B of Fig. 3) and skeletal muscle (panels C and D of Fig. 4). 
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Treatments with antibiotics or faecal samples totally or partially reversed the effect in 
both tissues, respectively (Fig. 4). 
 
 
Figure 4 Lipid (A, C) and protein (B, D) oxidative stress in liver (A, B) and skeletal 
muscle (C, D) in control (C), fructose-fed (F), fructose-fed+antibiotic (FA) and 
fructose-fed+faecal samples (FT) rats. Values are reported as means±SEM of six 
different rats. * P< .05 compared to C rats, # P< .05 compared to F rats (one-way 
ANOVA followed by Tukey post-test). 
 
4.4.5 Gut microbial composition 
In order to investigate whether the fructose-rich diet affected the gut microbial 
composition and whether the faecal transplant was able to rescue such effects we used a 
metagenomic approach. Caecal samples were collected from all rats and used to extract 
genomic DNA. The V4-V6 hypervariable region of the 16S bacterial gene was then 
amplified by a low-cycle PCR and the ≈ 500 bp amplicons obtained used for Illumina 
sequencing. For cost considerations and for the modest variability previously observed 
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in the gut microbial composition of animals under the same diet regimen41, the 
metagenomic analysis was performed by pooling together the DNA of the six replicates 
of each group as previously reported42. As detailed below, the analysis on pooled 
samples for rats of the control group was in agreement with previous data for rats under 
standard diet regimen [34] and showed a bacterial richness sufficient to observe 
significant reshaping of the gut microbiome following both antibiotic and 
transplantation treatments. 
A single run (SR-500) sequencing was performed and 5’ reads analysed by using 
QIIME pipeline19.  
 
 
Figure 5A. Relative OTUs (Operational Taxonomic Units) abundance at the Phylum 
level. The bar plot shows how the caecal microbiota distribution of each sample 
changes in rats of the various groups. Samples from animals treated with antibiotics 
(CA and FA) have very different composition compared to all other samples. (B-C) 
Variation of bacterial composition in/among the samples.  
 
The identified phylotypes show that the microbial community harbours two major phyla 
in all the five feeding groups: Firmicutes (91-40,6%) and Bacteroidetes (54,6- 6,2%) as 
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shown in Fig. 5A. Group C shows a microbial composition at the phylum level similar 
to that previously reported for rats under standard diet regimen28.  
The bacterial richness of the samples was estimated by Chao1 algorithm (alpha-
diversity metric) and showed an increased microbial complexity in samples C and FT 
compared to the other three groups (not shown). In order to analyze relationships among 
samples based on differences in phylogenetic diversity (beta-diversity metric), principle 
coordinates (PC) were calculated (Fig. 5B) using UniFrac distances26 between samples. 
Sample distribution in the PCoA plot (Fig. 5B) clearly shows that while samples CA 
and FA share a similar microbiota composition, they both strongly differ from the other 
three groups. This conclusion is in agreement with the taxonomical assignment at 
phylum level of Fig. 5A and is observed also within a phylogenetic tree using UPGMA 
algorithm (Fig. 5C). Not surprisingly, the microbial composition of the caecum of 
animals treated with antibiotics completely differs from that of animals not under 
antibiotic treatment.  
 
 
 
Figure 5B-C. Beta-diversity is shown by Principal Coordinates Analysis (PCoA), based 
on UniFrac method: C and FT samples cluster close to each other in the plot, such as 
CA with FA, while F sample occupies a different area. (C) Clustering of caecal 
microbiotas of rats, fed with different diets, was obtained by UPGMA algorithm. It 
shows that samples C and FT have a more similar composition compared to F sample 
and to CA and FA samples, according to PCoA distribution. 
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Because of the strong alterations caused by the antibiotic treatment, only data from C, F 
and FT groups were considered for the analysis of the variations at the genus taxonomic 
level.  
As shown in Fig. 6, most differences lies in the Firmicutes phylum with the 
Lactobacillus genus significantly decreased in fructose-fed animals (46.2%) in 
comparison with control animals (62,4%). Treatment with faecal samples (group FT) 
restored Lactobacillus representativeness (60,3%). The same trend of rescue of C 
microbial distribution is observed in other bacterial groups, for example, in the 
Erysipelotrichacaee family (C: 1.7%; F: 5.5%; FT: 1.0%) and the Ruminococcus genus 
(C: 5.8%; F: 17.3%; FT: 8.8%) and other genera listed in Table 1  
 
 
Fig. 6. Relative OTUs (Operational Taxonomic Units) abundance at the Genus level. 
Composition of caecal microbiota of rats from different diet groups as revealed by 
Illumina sequencing of V4-V6 hypervariable region of 16S rRNA gene. Population 
analyses for each diet group show major genera found. 
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It is interesting to observe that an increase in the relative abundance of members of the 
Erysipelotrichacaee family has been previously associated to a western diet and to 
obesity development in humanized gnotobiotic mice29.  
The presence of all bacterial genera reported in Table 1 was analyzed also in animals of 
groups CA and FA, treated with the antibiotic mixture. Interestingly, all genera present 
only in animals of group F and absent in groups C and FT are also absent in the animals 
under antibiotic treatment (not shown). Similarly, members of the Shewanella genus, 
found in groups C and FT but absent in group F (Table 1) were not found in antibiotic 
treated animals (not shown). 
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Table 1. Bacteria differentially distributed in the caecum of the different groups of rats. 
Phylum Class Order Family Genus Group Ca Group Fa Group FTa 
Actinobacteria Actinobacteria Actinomycetales Cellulomonadaceae Pseudoclavibacter ND 0.1 ND 
Promicromonosporaceae Promicromonospora ND 0.1 ND 
Firmicutes Bacilli Lactobacillales Aerococcaceae Aerococcus ND 0.1 ND 
Carnobacteriaceae Carnobacterium ND 0.1 ND 
Streptococcaceae Streptococcus ND 0.1 ND 
   Lactococcus 0.1 0.2 0.1 
 Lactobacillaceae Lactobacillus 62.7 46.3 60.4 
 Clostridia Clostridiales Ruminococcaceae Ruminococcus 9.8 17.3 8.9 
 Erysipelotrichi Erysipelotrichales Erysipelotrichaceae  1.8 5.6 0.9 
Proteobacteria Alphaproteobacteria Caulobacterales Caulobacteraceae Brevundimonas ND 0.1 ND 
 Gammaproteobacteria Pseudomonales Pseudomonaceae Pseudomonas ND 0.1 ND 
  Alteromonadales Shewanellaceae Shewanella 0.1 ND 0.1 
a Percentage of OTU abundance in the sample; ND: not detectable. 
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4.5 Discussion 
Main result of this study is that in fructose-fed rats the development of the metabolic 
syndrome directly correlates with the alteration of the microbial composition of the gut. 
Markers of metabolic syndrome, increased in fructose-fed rats, are reversed by 
treatment with an antibiotic mixture and partly by faecal transplant of rats under 
standard diet. Both treatments restore the gut microbiota, in terms of composition at the 
genus level and of overall diversity. 
It has been recently reported that microbiota transplantation through surgical extraction 
of donor caecal content and administration to the recipient rats by oral gavage was able 
to reshape indigenous gut microbial community to an extent not previously 
anticipated28. Here we show that a similar reshaping can be obtained without the need 
of surgical extraction of caecal bacteria, but simply using faecal content, and, more 
importantly, that the reshaping of gut microbiota occurs in concomitance with metabolic 
improvement in obese rats.  
The animal model used in the present study is represented by adult rats that become 
obese after long-term feeding with a fructose-rich diet6, 7, 14. Fructose-fed obese rats also 
display increased plasma NEFA, a reliable marker of the development of insulin 
resistance8, but this metabolic alteration is fully reversed by treatment with antibiotic or 
faecal samples. In addition, the inhibition of lipolysis by insulin in WAT is almost 
completely lost in fructose-fed rats, but treatment with antibiotic or faecal samples is 
able to restore insulin sensitivity at the level of control rats.  
The loss of insulin sensitivity in WAT can be driven by inflammation30, and here we 
show that fructose-fed rats exhibit higher plasma LPS and TNF-α, that could therefore 
contribute to derangements in WAT function. Treatment with antibiotic or faecal 
samples in fructose-fed rats greatly reduces plasma LPS and completely abolishes the 
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increase in plasma TNF-α, and these changes could be at the basis of the restored 
insulin sensitivity in WAT in these rats. The increased plasma LPS in fructose-fed rats 
and its reversal by antibiotic treatment is in agreement with previous findings obtained 
in mice made obese by high fat diet or high-fructose diet31-33. To our knowledge, for the 
first time we show that partial reversal of systemic inflammation can be obtained by 
faecal transplantation.  
The glucose intolerance found in fructose-fed rats was abolished by treatment with 
antibiotic but not by faecal transplant. The lack of effect of faecal transplant on glucose 
tolerance in the present study is at variance with results obtained in men34, but it should 
be taken into account that in the cited experiment the transplant was carried out by 
duodenal gavage. Skeletal muscle greatly contributes to glucose disposal under the 
control of insulin35, so we investigated a distal effector of insulin signalling in skeletal 
muscle, the kinase Akt. The degree of Akt activation was reduced by fructose-rich diet 
but significantly increased in fructose-fed rats treated with antibiotic. Since LPS directly 
induces insulin resistance in skeletal muscle36, and antibiotic treatment completely 
abolished the diet-induced increase in plasma LPS, the direct involvement of LPS in 
high fructose diet-induced glucose intolerance can be hypothesized.  
Our present results highlight an increased oxidative damage to lipid and proteins in liver 
and skeletal muscle of fructose-fed rats, that is fully prevented by antibiotic treatment, 
and only partly reversed by faecal transplant. This pattern of variation can be explained 
by modulation of plasma LPS by diet and treatments, since LPS has a well known pro-
oxidant effect37 . 
As expected, a fructose-rich diet induces signs of metabolic syndrome in rats and alters 
the microbial composition of the gut, decreasing the total bacterial diversity. The 
reduction of all markers of metabolic syndrome, inflammation and tissue oxidative 
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stress in animals under antibiotic treatment indicates that the metabolic disorders are 
somehow due to the fructose-induced alteration of the gut microbiota. Consistently, in 
fructose-fed rats treated with faecal samples of animals under standard diet, the 
microbial composition of the gut is restored and markers of metabolic syndrome, 
inflammation and tissue oxidative stress are significantly reduced. The antibiotic 
treatment strongly alters the gut microbial composition impairing a comparative 
analysis of the metagenomic data with those of animals not treated with antibiotics. 
However, as shown in Table 1, members of specific genera differentially represented in 
the various groups correlates with the metabolic data: genera present in group F and 
absent in C and FT are also absent in the metabolically similar groups CA and FA. On 
the same line, members of the Shewanella genus are present in all groups but group F, 
that is the only group with metabolic disorders.  
In conclusion, our data suggest that the alteration of the gut microbial composition 
correlates with the development of the metabolic syndrome and support the hypothesis 
that the manipulation of the gut microbiota is a promising therapeutic strategy in the 
treatment of diet-induced obesity and diabetes. 
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4.8 Supporting information 
 
 
Fig. S1. Body energy and lipid content (A), plasma non esterified fatty acids and area 
under the curve of plasma glucose after glucose load (B), plasma LPS and TNF-α  (C), 
epididymal fat weight and inhibitory effect of insulin on adipose tissue lipolysis (D), 
lipid and protein oxidative stress in liver (E), lipid and protein oxidative stress in 
skeletal muscle (F), in control (C) and control+antibiotic (CA)  rats. Values are 
reported as means±SEM of six different rats. EU=endotoxin unit. 
 
 
 
 
Fig. S2. Western blot of p-Akt and Akt in skeletal muscle in control, fructose-fed, 
fructose-fed+antibiotic and fructose-fed+faecal samples rats. 
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in Bacillus pumilus SF214
Nicola Manzo., Blanda Di Luccia., Rachele Isticato, Enrica D’Apuzzo, Maurilio De Felice, Ezio Ricca*
Department of Biology, Federico II University, Napoli, Italy
Abstract
Bacillus pumilus SF214 is a spore forming bacterium, isolated from a marine sample, able to produce a matrix and a orange-
red, water soluble pigment. Pigmentation is strictly regulated and high pigment production was observed during the late
stationary growth phase in a minimal medium and at growth temperatures lower than the optimum. Only a subpopulation
of stationary phase cells produced the pigment, indicating that the stationary culture contains a heterogeneous cell
population and that pigment synthesis is a bimodal phenomenon. The fraction of cells producing the pigment varied in the
different growth conditions and occured only in cells not devoted to sporulation. Only some of the pigmented cells were
also able to produce a matrix. Pigment and matrix production in SF214 appear then as two developmental fates both
alternative to sporulation. Since the pigment had an essential role in the cell resistance to oxidative stress conditions, we
propose that within the heterogeneous population different survival strategies can be followed by the different cells.
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Introduction
Spore-forming Bacilli are Gram positive organisms character-
ized by the ability to differentiate the endospore (spore), a
metabolically quiescent and extremely resistant cell type. The soil
is generally indicated as the main habitat of Bacilli, however, spores
have been found in many diverse environments, including rocks,
dust, aquatic environments, and the gut of various insects and
animals [1,2]. Such a wide environmental distribution is facilitated
by the spore ability to survive long-term absence of water and
nutrients and withstand extreme habitats that would kill other cell
types [3]. Survival is due to the peculiar structure of the spore that
is formed by a dehydrated cytoplasm containing a condensed and
inactive chromosome, and by a series of protective layers. An
innermost layer is the peptidoglycan-rich cortex that is itself
surrounded by additional layers of proteinaceous material, the
coat and, in some species, the exosporium [4,5]. Together these
components protect the spore from UV radiation, extremes of heat
or pH, exposure to solvents, hydrogen peroxide, toxic chemicals
and lytic enzymes [3,6]. In the presence of water and appropriate
nutrients the spore starts germination, a fast process during which
the protective structures are removed and resumption of vegetative
cell growth is allowed [3,4].
Spore formation is dependent upon environmental conditions
that do not allow cell growth, such as a block of DNA replication
and a decline of available nutrients [7]. In Bacillus subtilis, the
model organism for spore formers, growing cells are mainly single
and highly motile. When those dispersed cells reach the end of
exponential growth they can follow alternative developmental
pathways with some cells forming long chains, producing a
polymeric matrix rich in sugars and proteins (matrix) and
assembling into multicellular biofilms and others entering the
irreversible program of spore formation [8,9,10]. Therefore, in
dispersed cell populations matrix and spore production are
mutually exclusive cell fates [8,11] and are both bimodal processes
in which cells follow either one or the other pathway [12,13]. Both
developmental cell fates are governed by a regulatory protein,
Spo0A-P, that directly activates genes of the sporulation pathway
[14] and indirectly acts on matrix synthesis, relieving the
repression of genes for matrix production (epsA-O and yqxM-
sipW-tasA operons) [15,16,17]. Two mechanisms cooperate to
make sporulation and matrix production mutually exclusive: a
metabolic control mediated by the intracellular levels of SpoOA-P
and a chromosome copy number mechanism that prevents cells
that have entered the sporulation pathway from expressing matrix
genes [10]. Low levels of SpoOA-P induce matrix formation while
high levels of the phosphoprotein block matrix formation and
activate sporulation. Therefore, in a sporulation-inducing medi-
um, in which SpoOA-P levels rapidly rise, cells enter sporulation
instead of forming a biofilm. Conversely, in a medium in which
SpoOA-P remains at low levels biofilm formation is promoted
[10]. However, extracellular matrix production and sporulation
are linked. KinD, a membrane histidine kinase which is part of the
Spo0A phosphotransfer network, has been proposed to act as a
checkpoint protein able to regulate the onset of sporulation by
inhibiting Spo0A activity. KinD would alter its activity, depending
on the presence or absence of the extracellular matrix, thus
affecting the selective functionality on the master regulator Spo0A
to regulate expression of genes involved in matrix production and
sporulation [18]. Within a biofilm different cell types coexist and
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display a high degree of spatiotemporal organization with matrix-
producing cells that ultimately differentiate into spores [8].
Another interesting feature of some Bacilli is the production of
pigments. Isolates of several Bacillus species produce a wide variety
of pigments, from spore-associated melanin-like molecules [19] to
different types of carotenoids [20,21]. In some cases, those
carotenoids have been characterized and proposed to provide
resistance to UV irradiation and reactive oxygen species
[20,21,22,23]. A pigmented strain of Bacillus pumilus, SF214,
isolated from a marine sample, has been previously described [21].
SF214 is a moderate halophilic bacterium able to form a matrix
and to produce an orange to red water-soluble pigment, i.e. a
pigment that can not be partitioned into organic solvents but is
retained in the aqueous phase [21]. The inability to partition this
pigment into organic solvents, to resolve it by HPLC and to obtain
characteristic carotenoid UV/VIS spectra, has precluded its
definitive assignment as a carotenoid [21]. However, the spectral
peak at 410 nm shown by aqueous extracts of SF214 [21] is likely
to represent a protein-associated carotenoid, as previously
described for carotenoproteins extracted from crawfishes [24].
Here we report that in SF214 pigment production is a highly
regulated process that occurs during the stationary growth phase
only in cells not devoted to spore formation. Thus SF214 pigment
production appears as a bimodal phenomenon alternative to
sporulation, parallel to matrix biosynthesis and essential to grant
cell resistance to oxidative stress.
Results
Pigment Production is Dependent on Growth-phase,
–temperature and –medium
Synthesis of the water-soluble pigment produced by SF214 is a
strictly regulated process as it depends on the growth-phase,
-temperature and -medium. Pigment production was shown to be
strongly induced only 8–10 hours after that cells have entered the
stationary growth phase at 37uC in rich (LB) medium (Fig. 1A).
Although SF214 is a mesophilic bacterium and its optimal growth
temperature is 37uC, the maximal production of the pigment was
observed at 25uC (Fig. 1B). Compared with cells grown at 25uC a
slightly decreased production of pigment was observed at 30uC,
whereas more than 2-fold and about 6-fold decreased synthesis
was observed at 37uC and at 42uC, respectively (Fig. 1B). The
absorbance spectrum of cell extracts of SF214 between 300 and
500 nm [20] showed that cells grown at 25uC produced about 4-
fold more pigment in a minimal (S7; black symbols in Fig. 1C)
than in a rich (LB; gray symbols in Fig. 1C) medium, while in a
sporulation-inducing (DS; white symbols in Fig. 1A) medium the
synthesis of pigment was almost abolished.
Heterogeneity of Pigment Production
Previous reports have shown that carotenoids produced by the
yeast Phaffia rhodozyma [25] or the halotolerant green alga Dunaliella
salina [26] autofluoresce and that such property can be used to
follow carotenoid production by fluorescence microscopy. We
found that the water-soluble pigment of SF214 is also autofluor-
escent and that the fluorescence is not localized but rather diffuse
in the cell cytoplasm. Interestingly, in the cell culture only some of
the cells are fluorescent. Fig. 2 shows a representative microscopy
field observed by phase contrast (left) and fluorescent microscopy
either following the autofluorescence (middle) or after DAPI-
staining (right). The enlarged panels of Fig. 2 clearly show that
only some of the DAPI-stained cells were autofluorescent. The
number of autofluorescent cells varied with the growth conditions
(see below) but ranged between 20% in exponentially growing cells
to 80% in stationary cells. Ghost-like cells, negative to DAPI
staining and showing some autofluorescence were not considered.
It is interesting to observe in Fig. 2 a doublet of cells (white and
grey arrows in the enlarged sections). Those two cells seem to be
still partially attached and to derive from the same mother cell,
following the last round of division before stationary phase. Only
one of them (grey arrows) has switched to the ‘‘pigment state’’ and
is autofluorescent.
Two lines of evidence support our conclusion that the observed
autofluorescence was actually due to the water-soluble pigment: i)
unpigmented Bacilli (including other isolates of B. pumilus) (not
shown) and an unpigmented mutant of SF214 (described below)
did not show any fluorescence under identical experimental
conditions (Fig. 3); ii) the number of autofluorescent cells varied
consistently with the variations of pigment production observed at
various growth-phase, -temperature and -medium. As shown in
Fig. 4, the number of fluorescent cells was higher in a stationary
than in an exponential cultures (left panels), in cells grown at 25uC
than in cells grown at 37uC (middle panels) and in cells grown in
minimal (S7) than in rich medium (LB) (right panels). For each
condition considered in Fig. 4, different microscopy fields were
analyzed and over 1,000 cells for each condition counted. This
analysis indicated that the increased production of pigment
observed depending upon growth-phase, -temperature and
-medium is not due to a higher production of carotenoid by each
producing cell but rather to an increased proportion of cells able to
produce the pigment. Restriction of pigment synthesis to a
subpopulation of cells indicates that late stationary cultures of
SF214 contain a heterogeneous population of cells and that
pigment formation is a bimodal process.
Pigment Synthesis Only Occurs in Cells not Devoted to
Sporulation
Free spores as well as immature spores still contained within the
mother cells are known to autofluoresce [27]. We observed that
the fluorescence of sporangia containing an almost mature spore
was always limited to the prespore. Fig. 5 shows a representative
microscopy field with sporulating cells of SF214 observed by phase
contrast (left), autofluorescence (middle) and the merge (right):
while only some cells autofluoresced with a fluorescence diffused in
the cytoplasm, fluorescence associated to sporangia containing an
almost mature spore was confined to the forming spore, as no
fluorescence was visible within the cytoplasm. This observation,
together with experiments reported in Fig. 1C indicating that
when grown in a sporulation-inducing (DS) medium SF214 cells
did not produce the pigment, suggests that pigment production in
B. pumilus SF214 is mutually exclusive with spore formation.
To better address this point we analyzed SF214 cells by
pigment-driven autofluorescence (green) and by immunofluores-
cence due to anti-CotE primary antibody and fluorescent
secondary antibody (red). CotE is a spore coat protein [28],
produced early during sporulation, known to localize on the spore
surface [27]. For our analysis antibody raised against CotE of B.
subtilis were used [29]. In a preliminary experiment this antibody
was shown to specifically react against a protein of B. pumilus
SF214 corresponding in size to CotE of B. subtilis (Fig. S1). Fig. 6
reports representative microscopy fields of fluorescence and
immunofluorescence microscopy of SF214 cells grown in LB at
37uC up to the early stationary growth phase. In this analysis we
observed that, similarly to what observed in B. subtilis [27], B.
pumilus CotE is localized around the forming spore, and that cells
recognized by the anti-CotE antibody were all not autofluorescent.
We never observed yellow cells, which would have been indicative
of cells producing the pigment (green signal) and the spore-specific
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protein CotE (red signal) (see the merged panels of Fig. 6 for some
examples). Therefore, based on the experiments of Figs. 5 and 6
we conclude that pigment synthesis and sporulation are alternative
developmental pathways and occur in different cell subpopula-
tions.
Matrix Synthesis Occurs Only in a Subpopulation of
Pigmented Cells
In B. subtilis sporulation and matrix formation are alternative
developmental programmes [11]. Since SF214 also forms a matrix
[21] we verified whether also in this bacterium matrix formation
and sporulation are alternative and whether matrix and pigment
synthesis can occur in the same cells. To this aim we analyzed
SF214 cells by pigment-driven autofluorescence (green) and by
immunofluorescence due to anti-TasA primary antibody and
fluorescent secondary antibody (red). TasA is a major protein
component of the B. subtilis biofilm [15], encoded by the third gene
of the yqxM-sipW-tasA operon [16,30]. For our analysis we used
antibody raised against TasA of B. subtilis (a gift of A. Driks).
Preliminary experiments showed that a protein homologous to
TasA of B. subtilis can be extracted from spores of strain SF214 and
that this protein is recognized by the anti-TasA antibody (Fig. S2).
The homology with the protein of SF214 starts at position 24 of
TasA, which corresponds to the first amino acid residue of the
mature form of TasA after the proteolytic maturation of pre-TasA
[30,31] (Fig. S2). Fig. 7 reports representative fields of fluorescence
and immunofluorescence microscopy of SF214 cells grown in
minimal (S7) medium at 25uC up to the early stationary phase.
This analysis showed that: i) cells that were not autofluorescent
and therefore devoted to sporulation (indicated by white arrows in
Fig. 7A) were never recognized by the anti-TasA antibody, and ii)
only about 80% of the autofluorescent cells (from a total of approx.
1500 cells counted in 6 different microscopy fields) were
recognized by anti-TasA antibody (yellow cells in Fig. 7). Panel
B of Fig. 7 shows some examples of autofluorescent cells that are
not recognized by anti-TasA antibody. These results indicate that
Figure 1. Characterization of growth and pigment production in B. pumilus SF214. (A) Growth curve of B. pumilus SF214 at 37uC in rich (LB)
medium (black symbols) was determined by following over time the optical density of the culture at 600 nm. Pigment production (white symbols)
was determined by measuring over time the optical density of 1 ml of cell-free culture supernatant at 410 nm. (B) Growth rate (continuous line) and
pigment production (dashed line) of SF214 at different growth temperatures in rich (LB) medium. Pigment production was evaluated by measuring
the optical density of 1 ml of cell-free culture supernatant at 410 nm after 24 hours of growth. (C) Absorbance spectrum between 300 and 500 nm of
360 mg of cell extracts of SF214 grown at 25uC in minimal (S7) (black symbol), rich (LB) (gray symbol) and sporulation-inducing (DS) medium.
doi:10.1371/journal.pone.0062093.g001
Figure 2. Phase contrast and fluorescence microscopy analysis of SF214. Observation of the same microscopy field by phase contrast (left),
autofluorescence (middle) and DAPI staining (right). The same section of each panel is enlarged. The arrows in the enlarged sections point to a
doublet of cells, still partially attached and deriving from the same mother cell, in which only one cell (grey arrows) is autofluorescent.
doi:10.1371/journal.pone.0062093.g002
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as in B. subtilis also in B. pumilus SF214 sporulation and matrix
formation are alternative and that matrix synthesis occurs only in a
subpopulation of pigmented cells.
The Pigment of SF214 is Essential for Cell Resistance to
Hydrogen Peroxide
In non-photosynthetic organisms pigments have been associated
to cell resistance to UV irradiation and reactive oxygen species
[21,22,23]. To analyze the role of the SF214 pigment we isolated
an unpigmented mutant after nitrosoguanidine (NTG) mutagen-
esis [32] (Fig. S3). To this aim mid-exponential phase cells were
incubated for different times with 10 mg of NTG and the
percentage of survival assessed by CFU determination (Fig.
S3B). To minimize the possibility to have mutants carrying
multiple mutations, we only analyzed cells exposed to NTG for the
shortest time. NTG-treated cells were then diluted, plated and
checked for pigmentation after 36 hours of incubation at 25uC.
One unpigmented mutant, SF214-Mut, was chosen for further
analysis. Although we could not isolate the mutation responsible
for loss of pigmentation, as several attempts to transform SF214
with either plasmid or chromosomal DNA resulted unsuccessful
(not shown), we were able to show that the unpigmented
phenotype reverted spontaneously at a frequency of 1 clone out
of 109, thus suggesting that the NTG treatment had not produced
multiple mutations. Analysis of the aqueous extracts showed that
the mutant does not produce any molecule able to adsorb at
410 nm (Fig. S4) and, consistently, a fluorescence microscopy
analysis showed that no fluorescent cells were present in a
stationary phase culture of the unpigmented mutant (Fig. 3).
SF214 and its unpigmented derivative were used to analyze the
cell response to hydrogen peroxide. Cells of the two strains were
grown at 25uC in minimal (S7) liquid medium and collected 10
hours after the entry into stationary phase. Cells were then
incubated with 30 mM hydrogen peroxide and analyzed for
viability after various incubation times. While wild type cells were
all viable after exposure to hydrogen peroxide for up 30 minutes
and showed a reduced viability only after 45, 60 and 90 minutes of
treatment, the unpigmented mutant showed a clear decrease of
viability at all incubation times (Fig. 8). In a parallel experiment
spores of both strains were totally resistant to the hydrogen
peroxide treatment at all time points tested (Fig. 8). Results of Fig. 8
confirm that the pigment has a role in the response of vegetative
cells to oxidative stress. Spores do not contain the pigment but are
totally resistant to hydrogen peroxide due to other, pigment-
independent mechanisms [6,33].
Discussion
The main result of this report is the observation that pigment
production in SF214, a marine isolate of B. pumilus, is a bimodal
phenomenon alternative to sporulation. SF214 cells in stationary
growth phase form a heterogeneous population able to follow
diverse developmental fates. Some cells start the sporulation
programme while others produce the pigment. Only a subpopu-
lation of pigmented cells also produces a matrix. This is
reminiscent of the situation found in B. subtilis. Seminal studies
Figure 3. Microscopy analysis of SF214 and of its unpigmented mutant. Microscopy analysis of SF214 and of its unpigmented mutant
(SF214-Mut). For each strain the same microscopy field is shown by phase contrast (left) and autofluorescence (right). The same conditions of
exposure were used for the two microscopy fields.
doi:10.1371/journal.pone.0062093.g003
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performed using B. subtilis, the model organism for spore formers,
have shown that in dispersed cell populations spore formation,
matrix production, competence to acquire external DNA and
production of extra-cellular proteases are all bimodal processes
[9,10,12]. Spore and matrix formation appear as alternative
developmental pathways with some cells producing a matrix and
others entering the irreversible program of spore formation
[8,9,10]. In addition to those two also other cell fates are
alternative in B. subtilis: within a biofilm, only a subpopulation of
B. subtilis cells produce surfactin but, while surfactin-producers do
not respond to their own surfactin, other cells do and become
matrix producers. In this case, individual B. subtilis cells
simultaneously expressing genes for both surfactin and matrix
synthesis have never been observed [11]. These two subpopula-
tions do not include the entire population and the rest of the cells
that do not differentiate as surfactin or matrix producers probably
originate the other cell types known to be present in B. subtilis
populations [13]. In this frame each differentiation fate sets the
stage for a subsequent cell type. For example, within biofilms
matrix-producing cells are initially predominant and later
differentiate and become spores [8]. By analogy, we propose that
B. pumilus SF214 dispersed stationary cells also form a heteroge-
neous population able to follow diverse developmental fates. Some
cells enter the irreversible sporulation cycle forming the highly
resistant but metabolically quiescent spore while other cells follow
a different survival strategy and produce a pigment able to protect
the cell from oxidative conditions. Cell diversification and the
ability to develop different survival strategies in B. pumilus SF214
can then be viewed as a risk spreading (or bet hedging) strategy.
Such stochastic switches between phenotypic states have been
found in diverse organisms ranging from bacteria to humans and
are considered among the earliest evolutionary solutions to adapt
and facilitate persistence in fluctuating environments [34].
Only a subpopulation of pigment-producing cells forms an
extracellular matrix. It is not clear whether matrix-production can
also be viewed as a survival strategy in specific environments.
However, the existence of more than two developmental cell fates
is not surprising but rather expected on the base of the multiple
cell types previously observed in B. subtilis [7,13].
An additional result of this work is the observation that pigment
formation is a highly regulated process. Growth conditions affect
pigment synthesis most probably regulating the number of cells
that become able to synthesize the pigment. This conclusion is
supported by the number of fluorescent vs. not fluorescent cells in
Figure 4. Autofluorescence at different growth conditins. Microscopy fields of SF214 cells grown at different conditions and observed by
phase contrast and autofluorescence and compared to assess the proportion of fluorescent vs not fluorescent cells. Left panel: exponential vs.
stationary growth phase (in LB medium at 37uC); middle panel: 25uC vs. 37uC as growth temperature (in LB medium for 24 hours); right panel:
minimal (S7) vs. rich (LB) growth medium (stationary cells grown at 25uC). For each panel a graph reports the percentage of fluorescent (gray bars) vs.
not fluorescent (dark gray bars) cells. For each condition a total of 1.000 cells from five different microscopy fields were counted. Spores and cells
containing a prespore were not counted.
doi:10.1371/journal.pone.0062093.g004
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diverse microscopy fields (Fig. 4). Although our analysis does not
allow us to assess the amount of pigment synthesized at a single-
cell level in the various conditions, it clearly shows that a
regulation is exerted when the single stationary cell turns its fate
towards either sporulation or pigment synthesis.
Strain SF214 of B. pumilus is a field isolate and our attempts to
genetically manipulate it have been so far unsuccessful. Several
attempts to transform SF214 with chromosomal DNA of an
antibiotic-resistant strain of B. pumilus or with a non replicative
plasmid have all been unsuccessful. SF214 contains a large natural
plasmid. We obtained a cured strain which did not show apparent
phenotypic differences from SF214 but that was still refractory to
transformation. The impossibility to manipulate SF214 has so far
impaired a deeper molecular analysis of the various developmental
fates of SF214 and of the regulatory proteins involved. A future
challenging task will be to verify whether the master regulator
Spo0A, known to control matrix formation and sporulation, as
well as other cell fate regulators of B. subtilis such as ComX and
SinI/R, is also involved in pigment development in B. pumilus.
Methods
Bacterial Growth Conditions and Spore Induction and
Purification
Bacilli were grown either in LB medium (for 1 l: 10 g Bacto-
Tryptone, 5 g Bacto-yeast extract, 10 g NaCl, pH 7.0) or in Difco-
Sporulation-inducing (DS) medium or in minimal S7 medium
(50 mM MOPS, 10 mM (NH4)2SO4, 5 mM potassium phosphate
pH 7.0, 2 mM MgCl2, 0.9 mM CaCl2, 50 mM MnCl2, 10 mM
ZnCl2, 5 mM FeCl3, 2 mM thiamine hydrochloride, 20 mM
sodium glutamate, 1% glucose, 0.1 mg/ml phenylalanine,
0.1 mg/ml tryptophan) in aerobic conditions. For spore produc-
tion cells were grown in DS medium in aerobic conditions for 48
hours [32]. Spores were collected by centrifugation and purified by
repeated washes and lysozyme treatment, as previously reported
[35]. The B. subtilis strains used as reference were PY79 (wild type)
[36] and the isogenic BZ213 (cotE::cat) [28].
Pigment Extraction and Detection
For pigment extraction, cultures were centrifugated at
7000 rpm for 10 minutes. The cell pellet was suspended in a lysis
buffer (50 mM Tris-HCl pH 7.5, 1 mM DTT, 0.1 mM PMSF,
10% glycerol) and sonicated at 4uC for 10 min (30 sec. ON and
Figure 5. Autofluorescence of sporulating cells. The same microscopy field observed by phase contrast (left), autofluorescence (middle). The
right panel reports the merge of phase contrast and autofluorescence images. Cells were grown in rich (LB) medium for 15 hours.
doi:10.1371/journal.pone.0062093.g005
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Figure 6. Fluorescence and immunofluorescence microscopy with anti-CotE antibody. Microscopy analysis of cells from different fields
observed by phase contrast, DAPI-staining, immunofluorescence with anti-CotE primary antibody and Texas Red conjugated secondary antibody.
Merged panels of DAPI-immunofluorescence and autofluorescence-immunofluorescence are shown.
doi:10.1371/journal.pone.0062093.g006
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30 sec. OFF). The pellet was completely removed by centrifuga-
tion at 13000 rpm for 15 minutes. Protein concentration of the
various extracts was determined spectrophotometrically and
aliquots of identical protein concentration used to determine the
adsorbance spectrum between 300 and 550 nm, as previously
reported [21].
Hydrogen Peroxide Assays
Vegetative cells and spores were diluted to a concentration of
approximately 108 CFU/ml in PBS, and 1 ml of the cell
suspensions placed in a 1.5 ml microcentrifuge tube. 30 mM
H2O2 (Sigma) was added to the cell suspensions at the
concentration of 30 mM. Spores or cell suspensions were
incubated at room temperature with continous gentle mixing.
After various incubation times 100-ml samples were removed,
immediately diluted, plated onto LB agar plate and incubated in
order to determine the number of colonies.
Fluorescence and Immunofluorescence Microscopy
For autofluorescence and DAPI staining 200 ml aliquots of cell
culture were centrifuged (2 min 6,000 g) and cells resuspended in
20 ml of phosphate-buffered saline (PBS, pH 7.4). Only for the
DAPI staining PBS contained 0.1 mg/ml of 49,6-diamidino-2-
phenylindole dihydrochloride (DAPI). Six microliters of each
sample were placed on microscope slides and covered with a
coverslip previously treated for 30 seconds with poly-L-lysine
(Sigma). Samples were observed with an Olympus BX51
fluorescence microscope using a Fluorescein-Isothiocyanate
(FITC) or DAPI filters to visualize the fluorescence of the cells.
Typical acquisition times were 2000 ms for autofluorescence and
100 ms for DAPI and the Images were captured using a Olympus
DP70 digital camera and processed.
Immunofluorescence was performed essentially as described by
Azam et al (2000) [37], with a few modifications. Bacteria were
fixed for 1 hour at room temperature in 80% methanol, washed,
briefly treated with lysozyme and fixed to poly-L-lysine-treated
coverslip slides to improve micrographs resolution. The coverslips
were air dried and pretreated with 5% (w/v) dried milk in PBS,
prior to incubation overnight a 4uC with the primary antibodies.
In particular, a 1:400 diluition of anti-CotE (raised in mouse) and a
1:300 dilution for anti-TasA (raised in rabbit) were used. After ten
washes, the samples were incubated with a 1000-fold diluted
specific secondary antibody conjugates with Tetramethyl Rhoda-
mine, TRITC (Santa Cruz Biotechnology, Inc.) for 2 hours at
room temperature in the dark. After ten washes the coverslips were
covered with one drop (30 ml) of Component C (Slow Fade:
Molecular Probe S-2828) containing 0.1 mg/mL of DAPI. After 5
minutes the liquid was aspirated and the coverslips mounted onto
microscope slides adding one drop of Component A (Slow Fade:
Figure 7. Fluorescence and immunofluorescence microscopy with anti-TasA antibody. Microscopy analysis of cells from different fields
observed by phase contrast, immunofluorescence with anti-TasA primary antibody and Texas Red conjugated secondary antibody and
autofluorescence. Merged panels of autofluorescence-immunofluorescence are shown. Panel A reports examples of cells that are not autofluorescent
and that are also not recognized by anti-TasA, indicated by arrows. Panel B focuses on examples of autofluorescent cells, with some recognized
(yellow in the merge) and some not recognized by anti-TasA antibody.
doi:10.1371/journal.pone.0062093.g007
Figure 8. Cell and spore survival after treatment with H2O2. Cells and spores were treated with 30 mM H2O2 for various times. For each time
point the CFU of cells (gray symbols) and spores (white symbols) of the wild type (squares) and the mutant (circles) strains was obtained by plating on
LB plates and incubation for 24 hours at 37uC.
doi:10.1371/journal.pone.0062093.g008
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Molecular Probe S-2828). The microscope slides were analyzed as
described above.
Supporting Information
Figure S1 Western blot analysis of spore coat proteins
of SF214 with anti-CotE antobody. Purified spores were
extracted by SDS-DTT treatment as previously reported (Nichol-
son and Setlow, 1990), fractionated on 12% SDS-PAGE and
blotted on a PVDF membrane. The membrane was reacted with
antibody raised against the CotE protein of B. subtilis (Isticato
et al., 2010), then reacted against HRP-conjugated secondary
antibody and visualized by the ECL method. Coat proteins of a
wild type and an isogenic mutant lacking CotE of B. subtilis were
used as positive and negative control, respectively.
(TIF)
Figure S2 Characterization of TasA of B. pumilus
SF214. (A) An abundant protein extracted from SF214 spores
and corresponding in size to TasA of B. subtilis (28 kDa) was
transferred to a PVDF membrane and subjected to the Edman
degradation reaction. The determined N-terminal 20 residues are
reported. A Blast analysis identified the SF214 protein as an
homolog of TasA of B. subtilis with the homology starting at
position 24 of the B. subtilis protein. (B) Western blot analysis of
spore coat proteins of SF214. Purified spores were extracted with
SDS-DTT as previously reported (Nicholson and Setlow, 1990),
fractionated on 12% SDS-PAGE and blotted on a PVDF
membrane. The membrane was reacted with antibody raised
against the TasA protein of B. subtilis, then reacted against HRP-
conjugated secondary antibody and visualized by the ECL
method. Coat proteins of a wild type strain (PY79) of B. subtilis
were also used.
(TIF)
Figure S3 Isolation of an unpigmented mutant of SF214.
(A) SF214 wild type and unpigmented mutant (Mut) on a LB plate
grown at 25uC for 48 hours. (B) Survival of SF214 after treatment
with 10 mg of NTG for various times. Mid-exponential cells were
treated with NTG, washed twice, diluted, plated on LB plates and
incubated at 37uC for 36 hours.
(TIF)
Figure S4 Pigment production in SF214 and its unpig-
mented mutant. Adsorbance spectrum between 300 and
500 nm of 360 mg of cell extracts of SF214 wild type (black
symbols) and unpigmented mutant SF214-Mut (white symbols).
Cells of both strains were grown at 25uC for 24 hours.
(TIF)
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